Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	molecular adaptor activity	NCOR1 NCOR2 ATN1 WWC3 ITSN1 ITSN2 RNF20 GIGYF2 AKAP13 ZC3H18 RERE TNNT2 HDGFL2 NIPBL	1.29e-05	1356	55	14	GO:0060090
GeneOntologyMolecularFunction	chromo shadow domain binding	ATRX NIPBL	1.11e-04	6	55	2	GO:0070087
GeneOntologyMolecularFunction	protein-macromolecule adaptor activity	NCOR1 NCOR2 ATN1 WWC3 RNF20 AKAP13 ZC3H18 RERE TNNT2 HDGFL2 NIPBL	2.73e-04	1160	55	11	GO:0030674
GeneOntologyMolecularFunction	transcription corepressor activity	NCOR1 NCOR2 ATN1 RERE NIPBL	4.14e-04	229	55	5	GO:0003714
GeneOntologyMolecularFunction	mRNA binding	RBM25 LUC7L3 LUC7L2 RNF20 RNF40 EIF3A UPF3B UPF3A	5.88e-04	694	55	8	GO:0003729
GeneOntologyMolecularFunction	protein domain specific binding	NCOR1 ATN1 ATRX NF2 ENAH JDP2 AFDN RIMS1 NIPBL	5.93e-04	875	55	9	GO:0019904
GeneOntologyMolecularFunction	histone deacetylase binding	NCOR1 NCOR2 JDP2 NIPBL	7.18e-04	147	55	4	GO:0042826
GeneOntologyMolecularFunction	tropomyosin binding	CALD1 TNNT2	7.64e-04	15	55	2	GO:0005523
GeneOntologyMolecularFunction	chromatin binding	NCOR1 NCOR2 ATRX LEMD2 RNF20 JDP2 RERE NIPBL	8.85e-04	739	55	8	GO:0003682
GeneOntologyMolecularFunction	proline-rich region binding	ITSN1 GIGYF2	1.51e-03	21	55	2	GO:0070064
GeneOntologyMolecularFunction	nuclear retinoid X receptor binding	NCOR1 NCOR2	1.82e-03	23	55	2	GO:0046965
GeneOntologyMolecularFunction	small GTPase binding	GAS8 AFDN AKAP13 TNFAIP1 RIMS1	1.88e-03	321	55	5	GO:0031267
GeneOntologyMolecularFunction	actin binding	CALD1 NF2 MYO10 ENAH AFDN TNNT2	1.98e-03	479	55	6	GO:0003779
GeneOntologyMolecularFunction	cadherin binding	CALD1 CSNK1D GIGYF2 AFDN LRRC59	2.38e-03	339	55	5	GO:0045296
GeneOntologyMolecularFunction	Notch binding	NCOR2 KCTD10	2.50e-03	27	55	2	GO:0005112
GeneOntologyMolecularFunction	GTPase binding	GAS8 AFDN AKAP13 TNFAIP1 RIMS1	3.08e-03	360	55	5	GO:0051020
GeneOntologyMolecularFunction	protein serine kinase activity	CSNK1D MINK1 CDK11A MAP3K13 MAP4K4	3.19e-03	363	55	5	GO:0106310
GeneOntologyMolecularFunction	transcription coregulator activity	NCOR1 NCOR2 ATN1 RNF20 RERE NIPBL	4.36e-03	562	55	6	GO:0003712
GeneOntologyMolecularFunction	microfilament motor activity	MYO10 TNNT2	4.91e-03	38	55	2	GO:0000146
GeneOntologyMolecularFunction	cell adhesion molecule binding	CALD1 NF2 CSNK1D GIGYF2 AFDN LRRC59	5.92e-03	599	55	6	GO:0050839
GeneOntologyBiologicalProcess	developmental growth	NCOR1 ATN1 WWC3 ATRX ITSN2 GIGYF2 AFDN AKAP13 RIMS1 MAP3K13 HDGFL2 NIPBL	3.89e-06	911	55	12	GO:0048589
GeneOntologyBiologicalProcess	clathrin-dependent synaptic vesicle endocytosis	ITSN1 ITSN2	6.98e-06	2	55	2	GO:0150007
GeneOntologyBiologicalProcess	central nervous system development	NCOR1 NCOR2 ATN1 ATRX NF2 CSNK1D MINK1 GAS8 GIGYF2 AFDN UPF3B RERE NIPBL	1.17e-05	1197	55	13	GO:0007417
GeneOntologyBiologicalProcess	brain development	NCOR1 NCOR2 ATRX NF2 CSNK1D MINK1 GAS8 AFDN UPF3B RERE NIPBL	1.37e-05	859	55	11	GO:0007420
GeneOntologyBiologicalProcess	mRNA processing	RBM25 LUC7L3 PRPF40B LUC7L2 ZC3H13 SLTM CDK11A UPF3B UPF3A	1.38e-05	551	55	9	GO:0006397
GeneOntologyBiologicalProcess	growth	NCOR1 ATN1 WWC3 ATRX NF2 ITSN2 GIGYF2 AFDN AKAP13 RIMS1 MAP3K13 HDGFL2 NIPBL	1.63e-05	1235	55	13	GO:0040007
GeneOntologyBiologicalProcess	head development	NCOR1 NCOR2 ATRX NF2 CSNK1D MINK1 GAS8 AFDN UPF3B RERE NIPBL	2.56e-05	919	55	11	GO:0060322
GeneOntologyBiologicalProcess	regulation of mRNA processing	RBM25 SLTM CDK11A UPF3B UPF3A	6.32e-05	158	55	5	GO:0050684
GeneOntologyBiologicalProcess	positive regulation of mRNA cis splicing, via spliceosome	UPF3B UPF3A	6.95e-05	5	55	2	GO:1905746
GeneOntologyBiologicalProcess	regulation of mRNA cis splicing, via spliceosome	UPF3B UPF3A	6.95e-05	5	55	2	GO:1905744
GeneOntologyBiologicalProcess	positive regulation of dendrite extension	ITSN2 AFDN RIMS1	7.65e-05	31	55	3	GO:1903861
GeneOntologyBiologicalProcess	regulation of dendrite extension	ITSN2 AFDN RIMS1	1.11e-04	35	55	3	GO:1903859
GeneOntologyBiologicalProcess	mitotic sister chromatid cohesion	ATRX CDK11A NIPBL	1.20e-04	36	55	3	GO:0007064
GeneOntologyBiologicalProcess	regulation of developmental growth	NCOR1 WWC3 ITSN2 AFDN RIMS1 MAP3K13 NIPBL	1.22e-04	421	55	7	GO:0048638
GeneOntologyBiologicalProcess	mRNA metabolic process	RBM25 LUC7L3 PRPF40B LUC7L2 ZC3H13 SLTM CDK11A GIGYF2 UPF3B UPF3A	1.36e-04	917	55	10	GO:0016071
GeneOntologyBiologicalProcess	regulation of cell morphogenesis	NF2 MYO10 ITSN2 AFDN RIMS1 MAP3K13	1.49e-04	302	55	6	GO:0022604
GeneOntologyBiologicalProcess	regulation of hippo signaling	WWC3 NF2 MAP4K4	1.53e-04	39	55	3	GO:0035330
GeneOntologyBiologicalProcess	regulation of growth	NCOR1 WWC3 NF2 ITSN2 AFDN RIMS1 MAP3K13 HDGFL2 NIPBL	1.96e-04	777	55	9	GO:0040008
GeneOntologyBiologicalProcess	dendrite extension	ITSN2 AFDN RIMS1	2.51e-04	46	55	3	GO:0097484
GeneOntologyBiologicalProcess	positive regulation of cell growth	ITSN2 AFDN RIMS1 MAP3K13 HDGFL2	2.56e-04	213	55	5	GO:0030307
GeneOntologyBiologicalProcess	mRNA cis splicing, via spliceosome	PRPF40B UPF3B UPF3A	2.68e-04	47	55	3	GO:0045292
GeneOntologyBiologicalProcess	positive regulation of growth	ITSN2 AFDN RIMS1 MAP3K13 HDGFL2 NIPBL	2.77e-04	339	55	6	GO:0045927
GeneOntologyBiologicalProcess	synaptic vesicle recycling via endosome	ITSN1 ITSN2	3.10e-04	10	55	2	GO:0036466
GeneOntologyBiologicalProcess	RNA splicing	RBM25 LUC7L3 PRPF40B LUC7L2 ZC3H13 UPF3B UPF3A	3.58e-04	502	55	7	GO:0008380
GeneOntologyBiologicalProcess	mRNA splicing, via spliceosome	RBM25 LUC7L3 PRPF40B LUC7L2 UPF3B UPF3A	3.71e-04	358	55	6	GO:0000398
GeneOntologyBiologicalProcess	RNA splicing, via transesterification reactions with bulged adenosine as nucleophile	RBM25 LUC7L3 PRPF40B LUC7L2 UPF3B UPF3A	3.71e-04	358	55	6	GO:0000377
GeneOntologyBiologicalProcess	RNA splicing, via transesterification reactions	RBM25 LUC7L3 PRPF40B LUC7L2 UPF3B UPF3A	3.94e-04	362	55	6	GO:0000375
GeneOntologyBiologicalProcess	positive regulation of developmental growth	ITSN2 AFDN RIMS1 MAP3K13 NIPBL	4.26e-04	238	55	5	GO:0048639
GeneOntologyBiologicalProcess	hippo signaling	WWC3 NF2 MAP4K4	4.27e-04	55	55	3	GO:0035329
GeneOntologyBiologicalProcess	multicellular organism growth	NCOR1 ATN1 ATRX GIGYF2 NIPBL	5.24e-04	249	55	5	GO:0035264
GeneOntologyBiologicalProcess	maintenance of mitotic sister chromatid cohesion	ATRX NIPBL	5.34e-04	13	55	2	GO:0034088
GeneOntologyBiologicalProcess	chromatin organization	FAM50B NCOR1 ATRX RNF20 JDP2 RNF40 RERE HDGFL2 NIPBL	5.57e-04	896	55	9	GO:0006325
GeneOntologyBiologicalProcess	maintenance of sister chromatid cohesion	ATRX NIPBL	6.22e-04	14	55	2	GO:0034086
GeneOntologyBiologicalProcess	branching morphogenesis of a nerve	MAP3K13 RERE	7.17e-04	15	55	2	GO:0048755
GeneOntologyBiologicalProcess	sister chromatid cohesion	ATRX CDK11A NIPBL	7.62e-04	67	55	3	GO:0007062
GeneOntologyBiologicalProcess	synaptic vesicle endosomal processing	ITSN1 ITSN2	8.18e-04	16	55	2	GO:0099532
GeneOntologyBiologicalProcess	negative regulation of androgen receptor signaling pathway	NCOR1 NCOR2	9.25e-04	17	55	2	GO:0060766
GeneOntologyBiologicalProcess	cell morphogenesis	NF2 MYO10 MINK1 ITSN2 ENAH AFDN RIMS1 MAP3K13 RERE MAP4K4	1.10e-03	1194	55	10	GO:0000902
GeneOntologyBiologicalProcess	regulation of mRNA metabolic process	RBM25 SLTM CDK11A GIGYF2 UPF3B UPF3A	1.13e-03	443	55	6	GO:1903311
GeneOntologyBiologicalProcess	protein localization to cilium	CSNK1D GAS8 IQCE	1.14e-03	77	55	3	GO:0061512
GeneOntologyBiologicalProcess	negative regulation of intracellular signal transduction	NCOR1 NCOR2 WWC3 NF2 KCTD10 LEMD2 EIF3A TNFAIP1	1.15e-03	795	55	8	GO:1902532
GeneOntologyBiologicalProcess	protein-DNA complex organization	FAM50B NCOR1 ATRX RNF20 JDP2 RNF40 RERE HDGFL2 NIPBL	1.21e-03	999	55	9	GO:0071824
GeneOntologyBiologicalProcess	neuron projection morphogenesis	MINK1 ITSN2 ENAH AFDN RIMS1 MAP3K13 RERE MAP4K4	1.22e-03	802	55	8	GO:0048812
GeneOntologyBiologicalProcess	developmental cell growth	ITSN2 AFDN AKAP13 RIMS1 MAP3K13	1.23e-03	301	55	5	GO:0048588
GeneOntologyBiologicalProcess	actin cytoskeleton organization	CRACD CALD1 NF2 MINK1 ENAH AKAP13 TNFAIP1 TNNT2	1.23e-03	803	55	8	GO:0030036
GeneOntologyBiologicalProcess	cell growth	NF2 ITSN2 AFDN AKAP13 RIMS1 MAP3K13 HDGFL2	1.30e-03	625	55	7	GO:0016049
GeneOntologyBiologicalProcess	plasma membrane bounded cell projection morphogenesis	MINK1 ITSN2 ENAH AFDN RIMS1 MAP3K13 RERE MAP4K4	1.39e-03	819	55	8	GO:0120039
GeneOntologyBiologicalProcess	cell projection morphogenesis	MINK1 ITSN2 ENAH AFDN RIMS1 MAP3K13 RERE MAP4K4	1.47e-03	826	55	8	GO:0048858
GeneOntologyBiologicalProcess	ubiquitin-dependent protein catabolic process	CSNK1D KCTD10 SOCS5 RNF20 RNF40 TNFAIP1 UBXN1	1.49e-03	640	55	7	GO:0006511
GeneOntologyCellularComponent	U2-type prespliceosome	LUC7L3 PRPF40B LUC7L2	1.44e-05	18	56	3	GO:0071004
GeneOntologyCellularComponent	prespliceosome	LUC7L3 PRPF40B LUC7L2	1.44e-05	18	56	3	GO:0071010
GeneOntologyCellularComponent	nuclear body	NCOR2 RBM25 ATRX LUC7L3 PRPF40B LUC7L2 ZC3H13 SLTM AFDN ZC3H18 RERE	2.30e-05	903	56	11	GO:0016604
GeneOntologyCellularComponent	HULC complex	RNF20 RNF40	4.21e-05	4	56	2	GO:0033503
GeneOntologyCellularComponent	U1 snRNP	LUC7L3 PRPF40B LUC7L2	9.38e-05	33	56	3	GO:0005685
GeneOntologyCellularComponent	nuclear speck	RBM25 LUC7L3 PRPF40B LUC7L2 ZC3H13 AFDN ZC3H18	1.46e-04	431	56	7	GO:0016607
GeneOntologyCellularComponent	ubiquitin conjugating enzyme complex	RNF20 RNF40	2.51e-04	9	56	2	GO:0031371
GeneOntologyCellularComponent	cortical cytoskeleton	CALD1 NF2 AKAP13 RIMS1	3.97e-04	129	56	4	GO:0030863
GeneOntologyCellularComponent	actin cytoskeleton	CALD1 NF2 MYO10 ITSN1 ENAH AKAP13 TNNT2	8.37e-04	576	56	7	GO:0015629
GeneOntologyCellularComponent	exon-exon junction complex	UPF3B UPF3A	1.43e-03	21	56	2	GO:0035145
GeneOntologyCellularComponent	filopodium membrane	NF2 MYO10	1.43e-03	21	56	2	GO:0031527
GeneOntologyCellularComponent	histone deacetylase complex	NCOR1 NCOR2 RERE	1.54e-03	85	56	3	GO:0000118
GeneOntologyCellularComponent	cortical actin cytoskeleton	CALD1 NF2 AKAP13	1.99e-03	93	56	3	GO:0030864
GeneOntologyCellularComponent	spliceosomal snRNP complex	LUC7L3 PRPF40B LUC7L2	2.18e-03	96	56	3	GO:0097525
GeneOntologyCellularComponent	U2-type spliceosomal complex	LUC7L3 PRPF40B LUC7L2	2.25e-03	97	56	3	GO:0005684
GeneOntologyCellularComponent	small nuclear ribonucleoprotein complex	LUC7L3 PRPF40B LUC7L2	2.97e-03	107	56	3	GO:0030532
GeneOntologyCellularComponent	cell cortex	CALD1 NF2 MYO10 AKAP13 RIMS1	3.12e-03	371	56	5	GO:0005938
GeneOntologyCellularComponent	nuclear protein-containing complex	NCOR1 NCOR2 LUC7L3 PRPF40B LUC7L2 JDP2 UPF3B UPF3A RERE NIPBL	3.28e-03	1377	56	10	GO:0140513
GeneOntologyCellularComponent	lamellipodium	NF2 MYO10 ITSN1 ENAH	3.35e-03	230	56	4	GO:0030027
GeneOntologyCellularComponent	Sm-like protein family complex	LUC7L3 PRPF40B LUC7L2	4.00e-03	119	56	3	GO:0120114
GeneOntologyCellularComponent	filopodium	NF2 MYO10 ENAH	4.39e-03	123	56	3	GO:0030175
GeneOntologyCellularComponent	Cul3-RING ubiquitin ligase complex	KCTD10 TNFAIP1	4.90e-03	39	56	2	GO:0031463
GeneOntologyCellularComponent	presynaptic membrane	ITSN1 ITSN2 AFDN RIMS1	6.46e-03	277	56	4	GO:0042734
Domain	PH_13	ITSN1 ITSN2	8.83e-06	2	56	2	PF16652
Domain	Smg4_UPF3	UPF3B UPF3A	8.83e-06	2	56	2	PF03467
Domain	GPS2_interact	NCOR1 NCOR2	8.83e-06	2	56	2	PF15784
Domain	Nonsense_mediated_decay_UPF3	UPF3B UPF3A	8.83e-06	2	56	2	IPR005120
Domain	TMEM191C	TMEM191B TMEM191C	8.83e-06	2	56	2	PF15194
Domain	Atrophin-like	ATN1 RERE	8.83e-06	2	56	2	IPR002951
Domain	TMEM191B/C	TMEM191B TMEM191C	8.83e-06	2	56	2	IPR028186
Domain	Atrophin-1	ATN1 RERE	8.83e-06	2	56	2	PF03154
Domain	N-CoR_GPS2_interact	NCOR1 NCOR2	8.83e-06	2	56	2	IPR031557
Domain	BAT2_N	PRRC2C PRRC2B	2.64e-05	3	56	2	IPR009738
Domain	BAT2_N	PRRC2C PRRC2B	2.64e-05	3	56	2	PF07001
Domain	LUC7	LUC7L3 LUC7L2	2.64e-05	3	56	2	PF03194
Domain	Luc7-rel	LUC7L3 LUC7L2	2.64e-05	3	56	2	IPR004882
Domain	PRRC2	PRRC2C PRRC2B	2.64e-05	3	56	2	IPR033184
Domain	SANT_dom	NCOR1 NCOR2 RERE	6.32e-05	26	56	3	IPR017884
Domain	SANT	NCOR1 NCOR2 RERE	7.93e-05	28	56	3	PS51293
Domain	Myb_DNA-binding	NCOR1 NCOR2 RERE	1.56e-04	35	56	3	PF00249
Domain	MYB_LIKE	NCOR1 NCOR2 RERE	2.00e-04	38	56	3	PS50090
Domain	Acyl-CoA-binding_protein	MYO10 ACBD3	2.44e-04	8	56	2	IPR000582
Domain	EF-hand_4	ITSN1 ITSN2	3.91e-04	10	56	2	PF12763
Domain	-	NF2 MYO10 ACBD3	4.27e-04	49	56	3	1.20.80.10
Domain	SANT	NCOR1 NCOR2 RERE	4.53e-04	50	56	3	SM00717
Domain	FERM/acyl-CoA-bd_prot_3-hlx	NF2 MYO10 ACBD3	4.53e-04	50	56	3	IPR014352
Domain	EH	ITSN1 ITSN2	4.77e-04	11	56	2	PS50031
Domain	EH	ITSN1 ITSN2	4.77e-04	11	56	2	SM00027
Domain	EH_dom	ITSN1 ITSN2	4.77e-04	11	56	2	IPR000261
Domain	SANT/Myb	NCOR1 NCOR2 RERE	5.08e-04	52	56	3	IPR001005
Domain	CNH	MINK1 MAP4K4	7.85e-04	14	56	2	SM00036
Domain	C2	WWC3 ITSN1 ITSN2 RIMS1	8.66e-04	142	56	4	PS50004
Domain	CNH	MINK1 MAP4K4	9.04e-04	15	56	2	PS50219
Domain	CNH_dom	MINK1 MAP4K4	9.04e-04	15	56	2	IPR001180
Domain	CNH	MINK1 MAP4K4	9.04e-04	15	56	2	PF00780
Domain	-	WWC3 ITSN1 ITSN2 RIMS1	1.01e-03	148	56	4	2.60.40.150
Domain	GATA_ZN_FINGER_1	ATRX RERE	1.03e-03	16	56	2	PS00344
Domain	GATA_ZN_FINGER_2	ATRX RERE	1.03e-03	16	56	2	PS50114
Domain	-	NF2 MYO10 ITSN1 ITSN2 ENAH AKAP13	1.09e-03	391	56	6	2.30.29.30
Domain	RhoGEF	ITSN1 ITSN2 AKAP13	1.11e-03	68	56	3	SM00325
Domain	DH_2	ITSN1 ITSN2 AKAP13	1.21e-03	70	56	3	PS50010
Domain	RhoGEF	ITSN1 ITSN2 AKAP13	1.21e-03	70	56	3	PF00621
Domain	IQ	MYO10 CEP97 IQCE	1.26e-03	71	56	3	PF00612
Domain	DH-domain	ITSN1 ITSN2 AKAP13	1.26e-03	71	56	3	IPR000219
Domain	-	ITSN1 ITSN2 AKAP13	1.26e-03	71	56	3	1.20.900.10
Domain	C2_dom	WWC3 ITSN1 ITSN2 RIMS1	1.48e-03	164	56	4	IPR000008
Domain	PH_dom-like	NF2 MYO10 ITSN1 ITSN2 ENAH AKAP13	1.68e-03	426	56	6	IPR011993
Domain	IQ	MYO10 CEP97 IQCE	1.85e-03	81	56	3	SM00015
Domain	IQ_motif_EF-hand-BS	MYO10 CEP97 IQCE	2.49e-03	90	56	3	IPR000048
Domain	IQ	MYO10 CEP97 IQCE	2.74e-03	93	56	3	PS50096
Domain	Ser/Thr_kinase_AS	CSNK1D MINK1 CDK11A MAP3K13 MAP4K4	4.27e-03	357	56	5	IPR008271
Domain	S_TKc	CSNK1D MINK1 CDK11A MAP3K13 MAP4K4	4.37e-03	359	56	5	SM00220
Domain	PROTEIN_KINASE_ST	CSNK1D MINK1 CDK11A MAP3K13 MAP4K4	4.52e-03	362	56	5	PS00108
Domain	PH	MYO10 ITSN1 ITSN2 AKAP13	4.91e-03	229	56	4	PF00169
Domain	RA	MYO10 AFDN	5.21e-03	36	56	2	PF00788
Domain	Pkinase	CSNK1D MINK1 CDK11A MAP3K13 MAP4K4	5.60e-03	381	56	5	PF00069
Domain	-	RBM25 SLTM UPF3B UPF3A	6.13e-03	244	56	4	3.30.70.330
Domain	-	ZC3H13 ZC3H18	6.40e-03	40	56	2	4.10.1000.10
Domain	RA_dom	MYO10 AFDN	6.40e-03	40	56	2	IPR000159
Domain	C2	ITSN1 ITSN2 RIMS1	7.13e-03	131	56	3	PF00168
Domain	Nucleotide-bd_a/b_plait	RBM25 SLTM UPF3B UPF3A	7.45e-03	258	56	4	IPR012677
Domain	C2	ITSN1 ITSN2 RIMS1	8.06e-03	137	56	3	SM00239
Domain	FERM_M	NF2 MYO10	8.40e-03	46	56	2	PF00373
Pathway	WP_HIPPOYAP_SIGNALING	NF2 MINK1 MAP4K4	3.64e-05	22	42	3	M39821
Pathway	REACTOME_LOSS_OF_MECP2_BINDING_ABILITY_TO_THE_NCOR_SMRT_COMPLEX	NCOR1 NCOR2	1.80e-04	7	42	2	M27899
Pathway	REACTOME_NR1H2_NR1H3_REGULATE_GENE_EXPRESSION_TO_CONTROL_BILE_ACID_HOMEOSTASIS	NCOR1 NCOR2	3.08e-04	9	42	2	M29809
Pathway	KEGG_MEDICUS_REFERENCE_COHESIN_LOADING	ATRX NIPBL	3.08e-04	9	42	2	M47868
Pubmed	Large-scale characterization of HeLa cell nuclear phosphoproteins.	NCOR1 NCOR2 RBM25 ATN1 GSE1 ATRX ZC3H13 ITSN1 MINK1 RNF20 CDK11A GIGYF2 AFDN ZC3H18 RIMS1 RERE MAP4K4 NIPBL	1.42e-16	774	56	18	15302935
Pubmed	The Nse5/6-like SIMC1-SLF2 complex localizes SMC5/6 to viral replication centers.	ZNF711 NCOR1 NCOR2 RBM25 CALD1 ATRX LUC7L3 PRRC2C ZC3H13 SLTM CDK11A GIGYF2 AFDN LRRC59 ZC3H18 HDGFL2 NIPBL	8.80e-14	954	56	17	36373674
Pubmed	Identifications of novel host cell factors that interact with the receptor-binding domain of the SARS-CoV-2 spike protein.	ATN1 GSE1 ATRX LUC7L3 PRRC2C LUC7L2 MINK1 RNF20 SLTM GIGYF2 AFDN AKAP13 MAP4K4 PRRC2B	1.56e-12	650	56	14	38777146
Pubmed	TRIM33 drives prostate tumor growth by stabilizing androgen receptor from Skp2-mediated degradation.	NCOR1 NCOR2 RBM25 GSE1 ATRX LUC7L3 RNF20 RNF40 RERE	8.06e-11	220	56	9	35785414
Pubmed	H4K20me0 recognition by BRCA1-BARD1 directs homologous recombination to sister chromatids.	NCOR1 NCOR2 RBM25 ATRX LUC7L3 LUC7L2 ZC3H13 LEMD2 RNF20 SLTM JDP2 RNF40 LRRC59 ZC3H18 HDGFL2 NIPBL	1.26e-10	1294	56	16	30804502
Pubmed	Tagging genes with cassette-exchange sites.	NCOR1 NCOR2 LUC7L3 PRRC2C KCTD10 ENAH SLTM GIGYF2 AFDN AKAP13	1.45e-10	335	56	10	15741177
Pubmed	N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective.	CRACD GSE1 CALD1 ATRX PRRC2C ENAH GIGYF2 LRRC59 EIF3A UPF3B ACBD3 HDGFL2 NIPBL PRRC2B	1.88e-10	934	56	14	33916271
Pubmed	Assembly of the U5 snRNP component PRPF8 is controlled by the HSP90/R2TP chaperones.	LUC7L3 PRRC2C LUC7L2 ENAH RNF20 GIGYF2 AKAP13 RNF40 LRRC59 ZC3H18 EIF3A UPF3B UBXN1 ACBD3 HDGFL2 NIPBL	4.63e-10	1415	56	16	28515276
Pubmed	SMYD3 Impedes Small Cell Lung Cancer Sensitivity to Alkylation Damage through RNF113A Methylation-Phosphorylation Cross-talk.	NCOR2 RBM25 GSE1 LUC7L3 PRRC2C LUC7L2 LEMD2 GIGYF2 LRRC59 ZC3H18 RERE PRRC2B	4.72e-10	655	56	12	35819319
Pubmed	Synthetic Lethal and Resistance Interactions with BET Bromodomain Inhibitors in Triple-Negative Breast Cancer.	FAM50B NCOR1 NCOR2 RBM25 ATRX RNF20 SLTM RNF40 LRRC59 ZC3H18 EIF3A UBXN1 HDGFL2 NIPBL	5.45e-10	1014	56	14	32416067
Pubmed	Two-Dimensional Fractionation Method for Proteome-Wide Cross-Linking Mass Spectrometry Analysis.	FAM50B RBM25 CALD1 PRRC2C LUC7L2 ZC3H13 RNF20 RNF40 EIF3A UPF3B MAP4K4 HDGFL2 NIPBL	6.96e-10	847	56	13	35235311
Pubmed	Genome-wide CRISPR screens identify novel regulators of wild-type and mutant p53 stability.	NCOR1 NCOR2 GSE1 ATRX PRRC2C ITSN1 CDK11A RNF40 ZC3H18 UPF3B PRRC2B	2.20e-09	588	56	11	38580884
Pubmed	Comparative Application of BioID and TurboID for Protein-Proximity Biotinylation.	NCOR1 NCOR2 ATN1 GSE1 PRPF40B PRRC2C LUC7L2 LEMD2 ACBD3 PRRC2B	2.89e-09	457	56	10	32344865
Pubmed	Human transcription factor protein interaction networks.	NCOR1 NCOR2 RBM25 ATN1 GSE1 ATRX PRRC2C CDK11A GIGYF2 LRRC59 ZC3H18 EIF3A RERE NIPBL PRRC2B	4.96e-09	1429	56	15	35140242
Pubmed	KCTD13-mediated ubiquitination and degradation of GluN1 regulates excitatory synaptic transmission and seizure susceptibility.	CRACD CALD1 CSNK1D PRRC2C ITSN1 KCTD10 MINK1 ITSN2 AFDN LRRC59 EIF3A UPF3B RIMS1 TNNT2 PRRC2B	5.06e-09	1431	56	15	37142655
Pubmed	Defining the human deubiquitinating enzyme interaction landscape.	NF2 MYO10 KCTD10 GIGYF2 RNF40 LRRC59 ZC3H18 EIF3A UPF3B TNFAIP1 UBXN1 MAP4K4 PRRC2B	5.43e-09	1005	56	13	19615732
Pubmed	SR protein kinases promote splicing of nonconsensus introns.	GSE1 PRRC2C ZC3H13 SLTM AKAP13 ZC3H18 EIF3A UPF3B PRRC2B	6.24e-09	361	56	9	26167880
Pubmed	Complementary proteomics strategies capture an ataxin-1 interactome in Neuro-2a cells.	NCOR2 RBM25 GSE1 PRRC2C LUC7L2 CDK11A AFDN ZC3H18 EIF3A MAP4K4 HDGFL2	7.85e-09	665	56	11	30457570
Pubmed	The human cytoplasmic dynein interactome reveals novel activators of motility.	NCOR1 CALD1 CSNK1D LUC7L2 ITSN1 ITSN2 ENAH GIGYF2 AFDN MAP4K4 CEP97 PRRC2B	9.10e-09	853	56	12	28718761
Pubmed	Proximity-dependent Mapping of the Androgen Receptor Identifies Kruppel-like Factor 4 as a Functional Partner.	NCOR1 ATN1 GSE1 RNF20 RNF40 RERE NIPBL PRRC2B	1.16e-08	268	56	8	33640491
Pubmed	Characterization of an exchangeable gene trap using pU-17 carrying a stop codon-beta geo cassette.	NCOR1 NCOR2 RBM25 MYO10 KCTD10 MINK1 ENAH RERE MAP4K4 NIPBL	1.31e-08	536	56	10	15840001
Pubmed	Exchangeable gene trap using the Cre/mutated lox system.	NCOR1 NCOR2 RBM25 MYO10 KCTD10 MINK1 ENAH RERE MAP4K4 NIPBL	1.36e-08	538	56	10	10512203
Pubmed	SRCAP complex promotes lung cancer progression by reprograming the oncogenic transcription of Hippo-YAP/TAZ signaling pathway.	NCOR1 RBM25 CALD1 NF2 PRRC2C ENAH GIGYF2 AFDN MAP4K4 PRRC2B	1.64e-08	549	56	10	38280479
Pubmed	Intersectin (ITSN) family of scaffolds function as molecular hubs in protein interaction networks.	LUC7L3 ITSN1 KCTD10 ITSN2 RNF20 RNF40	2.63e-08	111	56	6	22558309
Pubmed	TBK1 phosphorylation activates LIR-dependent degradation of the inflammation repressor TNIP1.	RBM25 CALD1 NF2 LUC7L3 MYO10 LUC7L2 KCTD10 SLTM CDK11A LRRC59 EIF3A UPF3B	2.94e-08	949	56	12	36574265
Pubmed	Spatiotemporal profile of postsynaptic interactomes integrates components of complex brain disorders.	NCOR1 NCOR2 PRRC2C ITSN1 MINK1 ENAH GIGYF2 AFDN RIMS1 MAP4K4 NIPBL PRRC2B	3.45e-08	963	56	12	28671696
Pubmed	Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation.	RBM25 ATRX LUC7L3 LUC7L2 ENAH RNF20 SLTM GIGYF2 AFDN LRRC59 EIF3A UPF3B MAP4K4 NIPBL	4.07e-08	1425	56	14	30948266
Pubmed	The mRNA-bound proteome and its global occupancy profile on protein-coding transcripts.	RBM25 LUC7L3 PRRC2C LUC7L2 ZC3H13 SLTM GIGYF2 ZC3H18 EIF3A UPF3B PRRC2B	5.65e-08	807	56	11	22681889
Pubmed	Dynamic Protein Interactions of the Polycomb Repressive Complex 2 during Differentiation of Pluripotent Cells.	ATRX CSNK1D PRRC2C SLTM LRRC59 ZC3H18 UPF3B HDGFL2 CEP97	5.90e-08	469	56	9	27634302
Pubmed	BCOR modulates transcriptional activity of a subset of glucocorticoid receptor target genes involved in cell growth and mobility.	NCOR1 NCOR2 GSE1 PRRC2B	6.25e-08	24	56	4	33722704
Pubmed	Large-scale mapping of human protein-protein interactions by mass spectrometry.	RBM25 ATRX LUC7L3 CSNK1D LUC7L2 GAS8 AFDN AKAP13 LRRC59 EIF3A RIMS1 UBXN1 HDGFL2	9.60e-08	1284	56	13	17353931
Pubmed	Histone deacetylase-associating Atrophin proteins are nuclear receptor corepressors.	NCOR2 ATN1 RERE	1.38e-07	7	56	3	16481466
Pubmed	Multiplexed kinase interactome profiling quantifies cellular network activity and plasticity.	NCOR2 CALD1 ATRX CSNK1D MINK1 CDK11A UPF3B MAP3K13 UBXN1 MAP4K4 HDGFL2	1.88e-07	910	56	11	36736316
Pubmed	Characterizing ZC3H18, a Multi-domain Protein at the Interface of RNA Production and Destruction Decisions.	CRACD RBM25 LUC7L3 PRRC2C LUC7L2 ZC3H13 SLTM LRRC59 ZC3H18 EIF3A	2.36e-07	731	56	10	29298432
Pubmed	Prediction of the coding sequences of mouse homologues of KIAA gene: II. The complete nucleotide sequences of 400 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.	CRACD GSE1 MYO10 PRRC2C ITSN2 GIGYF2 RERE PRRC2B	2.86e-07	407	56	8	12693553
Pubmed	Mapping the Ku Interactome Using Proximity-Dependent Biotin Identification in Human Cells.	ZNF711 NCOR1 ATRX CDK11A LRRC59 ZC3H18 HDGFL2	3.62e-07	283	56	7	30585729
Pubmed	CHD3 and CHD4 form distinct NuRD complexes with different yet overlapping functionality.	RBM25 LUC7L3 PRRC2C LUC7L2 ZC3H13 LRRC59 ZC3H18 EIF3A HDGFL2	5.03e-07	605	56	9	28977666
Pubmed	Identification and Functional Characterization of a Novel Androgen Receptor Coregulator, EAP1.	NCOR2 GSE1 RNF20 RNF40	5.27e-07	40	56	4	34585037
Pubmed	Genetic and Proteomic Interrogation of Lower Confidence Candidate Genes Reveals Signaling Networks in β-Catenin-Active Cancers.	NCOR1 NCOR2 RBM25 ATN1 WWC3 NF2 CSNK1D LUC7L2 LRRC59 UPF3B UPF3A ACBD3	5.56e-07	1247	56	12	27684187
Pubmed	The protein network surrounding the human telomere repeat binding factors TRF1, TRF2, and POT1.	ATN1 CALD1 MYO10 ZC3H13 SLTM RNF40	7.85e-07	197	56	6	20811636
Pubmed	Chemoproteomics profiling of HDAC inhibitors reveals selective targeting of HDAC complexes.	NCOR1 NCOR2 GSE1 RERE	8.55e-07	45	56	4	21258344
Pubmed	Combinatorial targeting of a chromatin complex comprising Dot1L, menin and the tyrosine kinase BAZ1B reveals a new therapeutic vulnerability of endocrine therapy-resistant breast cancer.	NCOR1 RBM25 LUC7L3 LUC7L2 ZC3H13 SLTM GIGYF2 LRRC59 ZC3H18 EIF3A	9.00e-07	847	56	10	35850772
Pubmed	RSPO-LGR4 functions via IQGAP1 to potentiate Wnt signaling.	RBM25 PRRC2C GIGYF2 AFDN ZC3H18 EIF3A	9.09e-07	202	56	6	24639526
Pubmed	Functional proteomics establishes the interaction of SIRT7 with chromatin remodeling complexes and expands its role in regulation of RNA polymerase I transcription.	RBM25 PRRC2C ZC3H13 SLTM GIGYF2 AFDN ZC3H18 NIPBL PRRC2B	9.47e-07	653	56	9	22586326
Pubmed	MECP2 directly interacts with RNA polymerase II to modulate transcription in human neurons.	RBM25 LUC7L3 LUC7L2 ZC3H13 KCTD10 SLTM LRRC59 ZC3H18 UPF3A MAP4K4 NIPBL	1.04e-06	1082	56	11	38697112
Pubmed	Poly(ADP-ribosyl)ation of BRD7 by PARP1 confers resistance to DNA-damaging chemotherapeutic agents.	RBM25 LUC7L3 PRRC2C LUC7L2 CDK11A LRRC59 EIF3A UPF3B	1.08e-06	486	56	8	30940648
Pubmed	Interaction network of human early embryonic transcription factors.	NCOR1 NCOR2 ATN1 GSE1 RERE NIPBL PRRC2B	1.52e-06	351	56	7	38297188
Pubmed	BioID-based intact cell interactome of the Kv1.3 potassium channel identifies a Kv1.3-STAT3-p53 cellular signaling pathway.	RBM25 CALD1 PRRC2C MINK1 GIGYF2 AFDN LRRC59 ZC3H18 MAP4K4	1.84e-06	708	56	9	39231216
Pubmed	Defining the membrane proteome of NK cells.	NCOR1 NCOR2 NF2 PRRC2C LEMD2 GIGYF2 AKAP13 RNF40 LRRC59 EIF3A ACBD3	2.18e-06	1168	56	11	19946888
Pubmed	Optimized fragmentation schemes and data analysis strategies for proteome-wide cross-link identification.	NCOR2 ATRX MYO10 RNF20 SLTM RNF40 EIF3A HDGFL2	2.30e-06	538	56	8	28524877
Pubmed	Quantitative Proteomics Links the LRRC59 Interactome to mRNA Translation on the ER Membrane.	CALD1 PRRC2C GIGYF2 AFDN LRRC59 EIF3A ACBD3	2.36e-06	375	56	7	32788342
Pubmed	In-Depth In Vivo Crosslinking in Minutes by a Compact, Membrane-Permeable, and Alkynyl-Enrichable Crosslinker.	NCOR1 CALD1 ATRX PRRC2C ITSN1 ITSN2 LRRC59 EIF3A RIMS1 HDGFL2 NIPBL PRRC2B	2.53e-06	1442	56	12	35575683
Pubmed	Novel splicing factor RBM25 modulates Bcl-x pre-mRNA 5' splice site selection.	RBM25 LUC7L3	2.55e-06	2	56	2	18663000
Pubmed	Aberrant corepressor interactions implicated in PML-RAR(alpha) and PLZF-RAR(alpha) leukemogenesis reflect an altered recruitment and release of specific NCoR and SMRT splice variants.	NCOR1 NCOR2	2.55e-06	2	56	2	21131350
Pubmed	Regulation of corepressor alternative mRNA splicing by hormonal and metabolic signaling.	NCOR1 NCOR2	2.55e-06	2	56	2	26166430
Pubmed	E3 Ubiquitin Ligases RNF20 and RNF40 Are Required for Double-Stranded Break (DSB) Repair: Evidence for Monoubiquitination of Histone H2B Lysine 120 as a Novel Axis of DSB Signaling and Repair.	RNF20 RNF40	2.55e-06	2	56	2	30692271
Pubmed	Deficiency in mammalian histone H2B ubiquitin ligase Bre1 (Rnf20/Rnf40) leads to replication stress and chromosomal instability.	RNF20 RNF40	2.55e-06	2	56	2	22354749
Pubmed	RNF20 and RNF40 regulate vitamin D receptor-dependent signaling in inflammatory bowel disease.	RNF20 RNF40	2.55e-06	2	56	2	34088983
Pubmed	Cooperative NCoR/SMRT interactions establish a corepressor-based strategy for integration of inflammatory and anti-inflammatory signaling pathways.	NCOR1 NCOR2	2.55e-06	2	56	2	19299558
Pubmed	Unique forms of human and mouse nuclear receptor corepressor SMRT.	NCOR1 NCOR2	2.55e-06	2	56	2	10077563
Pubmed	Spatial expression of the nonsense-mediated mRNA decay factors UPF3A and UPF3B among mouse tissues.	UPF3B UPF3A	2.55e-06	2	56	2	37961809
Pubmed	NCoR/SMRT co-repressors cooperate with c-MYC to create an epigenetic barrier to somatic cell reprogramming.	NCOR1 NCOR2	2.55e-06	2	56	2	29531310
Pubmed	Vertebrate intersectin1 is repurposed to facilitate cortical midline connectivity and higher order cognition.	ITSN1 ITSN2	2.55e-06	2	56	2	23447614
Pubmed	Intersectin deficiency impairs cortico-striatal neurotransmission and causes obsessive-compulsive behaviors in mice.	ITSN1 ITSN2	2.55e-06	2	56	2	37603735
Pubmed	CREBBP Inactivation Promotes the Development of HDAC3-Dependent Lymphomas.	NCOR1 NCOR2	2.55e-06	2	56	2	27733359
Pubmed	Protein binding of a DRPLA family through arginine-glutamic acid dipeptide repeats is enhanced by extended polyglutamine.	ATN1 RERE	2.55e-06	2	56	2	10814707
Pubmed	Nuclear Receptor Corepressors NCOR1 and SMRT Regulate Metabolism via Intestinal Regulation of Carbohydrate Transport.	NCOR1 NCOR2	2.55e-06	2	56	2	39106294
Pubmed	Schwannomin inhibits tumorigenesis through direct interaction with the eukaryotic initiation factor subunit c (eIF3c).	NF2 EIF3A	2.55e-06	2	56	2	16497727
Pubmed	The human intersectin genes and their spliced variants are differentially expressed.	ITSN1 ITSN2	2.55e-06	2	56	2	11690630
Pubmed	Mutations in UPF3B, a member of the nonsense-mediated mRNA decay complex, cause syndromic and nonsyndromic mental retardation.	UPF3B UPF3A	2.55e-06	2	56	2	17704778
Pubmed	Exon Inclusion Modulates Conformational Plasticity and Autoinhibition of the Intersectin 1 SH3A Domain.	ITSN1 ITSN2	2.55e-06	2	56	2	31031201
Pubmed	Corepressors (NCoR and SMRT) as well as coactivators are recruited to positively regulated 1α,25-dihydroxyvitamin D3-responsive genes.	NCOR1 NCOR2	2.55e-06	2	56	2	22944139
Pubmed	Intersectin associates with synapsin and regulates its nanoscale localization and function.	ITSN1 ITSN2	2.55e-06	2	56	2	29078407
Pubmed	RNF20/RNF40 ameliorates streptozotocin-induced type 1 diabetes by activating vitamin D receptors in vivo.	RNF20 RNF40	2.55e-06	2	56	2	37422774
Pubmed	Deficiency in Bre1 impairs homologous recombination repair and cell cycle checkpoint response to radiation damage in mammalian cells.	RNF20 RNF40	2.55e-06	2	56	2	20738173
Pubmed	The U1 snRNP-associated factor Luc7p affects 5' splice site selection in yeast and human.	LUC7L3 LUC7L2	2.55e-06	2	56	2	17726058
Pubmed	Mammalian UPF3A and UPF3B can activate nonsense-mediated mRNA decay independently of their exon junction complex binding.	UPF3B UPF3A	2.55e-06	2	56	2	35451102
Pubmed	Evolution of NCoR-1 and NCoR-2 corepressor alternative mRNA splicing in placental mammals.	NCOR1 NCOR2	2.55e-06	2	56	2	31208445
Pubmed	Human UPF3A and UPF3B enable fault-tolerant activation of nonsense-mediated mRNA decay.	UPF3B UPF3A	2.55e-06	2	56	2	35451084
Pubmed	Massively parallel in vivo CRISPR screening identifies RNF20/40 as epigenetic regulators of cardiomyocyte maturation.	RNF20 RNF40	2.55e-06	2	56	2	34290256
Pubmed	Adaptor proteins intersectin 1 and 2 bind similar proline-rich ligands but are differentially recognized by SH2 domain-containing proteins.	ITSN1 ITSN2	2.55e-06	2	56	2	23936226
Pubmed	Irisin Mediates Effects on Bone and Fat via αV Integrin Receptors.	NCOR2 RBM25 ATN1 LUC7L2 ENAH RNF20 CDK11A RNF40 LRRC59 RERE MAP4K4 ACBD3	2.70e-06	1451	56	12	30550785
Pubmed	TXLNA enhances TBK1 phosphorylation by suppressing PPM1B recruitment.	ATRX LUC7L3 PRRC2C ENAH UPF3B	2.97e-06	138	56	5	37506885
Pubmed	Tau interactome maps synaptic and mitochondrial processes associated with neurodegeneration.	NF2 CSNK1D ENAH AFDN LRRC59 EIF3A RIMS1 MAP4K4	3.02e-06	558	56	8	35063084
Pubmed	Does 3D Phenotyping Yield Substantial Insights in the Genetics of the Mouse Mandible Shape?	KCTD10 AKAP13 RERE	3.17e-06	18	56	3	26921296
Pubmed	Atrophin 2 recruits histone deacetylase and is required for the function of multiple signaling centers during mouse embryogenesis.	ATN1 ATRX RERE	3.17e-06	18	56	3	14645126
Pubmed	Human Antiviral Protein IFIX Suppresses Viral Gene Expression during Herpes Simplex Virus 1 (HSV-1) Infection and Is Counteracted by Virus-induced Proteasomal Degradation.	ATRX LUC7L3 GIGYF2 ZC3H18 HDGFL2 PRRC2B	3.19e-06	251	56	6	28077445
Pubmed	E-cadherin interactome complexity and robustness resolved by quantitative proteomics.	CALD1 NF2 CSNK1D MINK1 GIGYF2 AFDN LRRC59 ACBD3	3.31e-06	565	56	8	25468996
Pubmed	Therapeutic targeting of the USP2-E2F4 axis inhibits autophagic machinery essential for zinc homeostasis in cancer progression.	NCOR1 RBM25 LUC7L2 SLTM EIF3A UBXN1 PRRC2B	3.79e-06	403	56	7	35253629
Pubmed	Proximity-dependent biotin identification (BioID) reveals a dynamic LSD1-CoREST interactome during embryonic stem cell differentiation.	NCOR1 NCOR2 GSE1 LUC7L2 GIGYF2 RNF40 RERE	4.81e-06	418	56	7	34709266
Pubmed	Identifying biological pathways that underlie primordial short stature using network analysis.	RBM25 CALD1 LUC7L3 SLTM GIGYF2 AFDN LRRC59 EIF3A MAP4K4 NIPBL	4.88e-06	1024	56	10	24711643
Pubmed	SARS-CoV-2 uses Spike glycoprotein to control the host's anaerobic metabolism by inhibiting LDHB.	RBM25 LUC7L3 PRRC2C LUC7L2 CDK11A GIGYF2 LRRC59 EIF3A	5.59e-06	607	56	8	39147351
Pubmed	Targeting SKA3 suppresses the proliferation and chemoresistance of laryngeal squamous cell carcinoma via impairing PLK1-AKT axis-mediated glycolysis.	RBM25 LUC7L3 LEMD2 SLTM	5.72e-06	72	56	4	33106477
Pubmed	Systematically defining selective autophagy receptor-specific cargo using autophagosome content profiling.	NCOR1 CSNK1D PRRC2C SLTM AKAP13 LRRC59 EIF3A UPF3B UBXN1 NIPBL PRRC2B	5.92e-06	1297	56	11	33545068
Pubmed	Identification of proximal SUMO-dependent interactors using SUMO-ID.	NCOR1 NCOR2 CALD1 RNF20 SLTM RNF40 CEP97	7.13e-06	444	56	7	34795231
Pubmed	Systematic mapping of genetic interactions for de novo fatty acid synthesis identifies C12orf49 as a regulator of lipid metabolism.	CRACD ATRX NF2 MYO10 RNF20 SLTM GIGYF2 ZC3H18 RERE MAP4K4 NIPBL	7.35e-06	1327	56	11	32694731
Pubmed	Functional interactions with Pit-1 reorganize co-repressor complexes in the living cell nucleus.	NCOR1 NCOR2	7.63e-06	3	56	2	16030140
Pubmed	Functional analyses of human LUC7-like proteins involved in splicing regulation and myeloid neoplasms.	LUC7L3 LUC7L2	7.63e-06	3	56	2	33852859
Pubmed	Role of RBM25/LUC7L3 in abnormal cardiac sodium channel splicing regulation in human heart failure.	RBM25 LUC7L3	7.63e-06	3	56	2	21859973
Pubmed	Nuclear Receptor CoRepressors, NCOR1 and SMRT, are required for maintaining systemic metabolic homeostasis.	NCOR1 NCOR2	7.63e-06	3	56	2	34390859
Interaction	FXR1 interactions	NCOR1 NCOR2 ATN1 PRRC2C LUC7L2 ITSN1 KCTD10 GIGYF2 AFDN LRRC59 EIF3A UPF3B TNFAIP1 MAP4K4 PRRC2B	1.79e-10	679	54	15	int:FXR1
Interaction	SMC5 interactions	ZNF711 NCOR1 NCOR2 RBM25 CALD1 ATRX LUC7L3 PRRC2C ZC3H13 SLTM CDK11A GIGYF2 AFDN LRRC59 ZC3H18 HDGFL2 NIPBL	4.86e-10	1000	54	17	int:SMC5
Interaction	SP7 interactions	NCOR1 NCOR2 RBM25 ATN1 GSE1 GAS8 CDK11A RERE NIPBL PRRC2B	7.01e-09	304	54	10	int:SP7
Interaction	EGR2 interactions	NCOR1 NCOR2 ATN1 RNF20 RNF40 RERE NIPBL PRRC2B	1.70e-08	171	54	8	int:EGR2
Interaction	CSNK2A1 interactions	NCOR1 ATN1 CALD1 ATRX PRRC2C LUC7L2 ZC3H13 MINK1 CDK11A LRRC59 ZC3H18 EIF3A UPF3B MAP3K13 HDGFL2	1.89e-08	956	54	15	int:CSNK2A1
Interaction	ALG13 interactions	NCOR1 NCOR2 RBM25 ATN1 GSE1 PRRC2C RERE PRRC2B	2.89e-08	183	54	8	int:ALG13
Interaction	KCTD13 interactions	CRACD CALD1 CSNK1D PRRC2C ITSN1 KCTD10 MINK1 ITSN2 AFDN LRRC59 EIF3A UPF3B TNFAIP1 RIMS1 TNNT2 CEP97 PRRC2B	6.97e-08	1394	54	17	int:KCTD13
Interaction	NUP43 interactions	ZNF711 NCOR1 NCOR2 ATN1 GSE1 LUC7L3 PRRC2C LUC7L2 ZC3H13 ZC3H18 RERE NIPBL	7.43e-08	625	54	12	int:NUP43
Interaction	NUP35 interactions	NCOR1 NCOR2 ATN1 GSE1 PRPF40B PRRC2C LEMD2 AFDN ACBD3 PRRC2B	1.60e-07	424	54	10	int:NUP35
Interaction	RNPS1 interactions	RBM25 LUC7L3 LUC7L2 ITSN1 ITSN2 CDK11A RNF40 ZC3H18 UPF3B UPF3A	1.64e-07	425	54	10	int:RNPS1
Interaction	CNOT9 interactions	PRRC2C MINK1 RNF20 GIGYF2 MAP4K4 ACBD3 CEP97 PRRC2B	1.74e-07	231	54	8	int:CNOT9
Interaction	NAA40 interactions	CRACD GSE1 CALD1 ATRX PRRC2C ENAH GIGYF2 LRRC59 EIF3A UPF3B ACBD3 HDGFL2 NIPBL PRRC2B	1.93e-07	978	54	14	int:NAA40
Interaction	RNF113A interactions	NCOR2 RBM25 GSE1 LUC7L3 PRRC2C LUC7L2 LEMD2 GIGYF2 LRRC59 ZC3H18 RERE PRRC2B	2.23e-07	692	54	12	int:RNF113A
Interaction	INSYN1 interactions	NCOR1 NCOR2 MINK1 RNF20 AKAP13 RNF40 MAP4K4	3.27e-07	169	54	7	int:INSYN1
Interaction	MEN1 interactions	NCOR1 RBM25 ATN1 GSE1 ATRX LUC7L3 ZC3H13 RNF20 SLTM GIGYF2 AFDN ZC3H18 EIF3A RERE	3.58e-07	1029	54	14	int:MEN1
Interaction	CSNK2B interactions	ATRX LUC7L2 ITSN1 MINK1 LEMD2 CDK11A LRRC59 ZC3H18 TNFAIP1 MAP4K4 HDGFL2	6.66e-07	625	54	11	int:CSNK2B
Interaction	SNRNP40 interactions	NCOR1 NCOR2 RBM25 ATN1 GSE1 LUC7L3 PRPF40B ZC3H13 ITSN2 ZC3H18 HDGFL2	8.03e-07	637	54	11	int:SNRNP40
Interaction	MECP2 interactions	NCOR1 RBM25 ATRX LUC7L3 PRPF40B CSNK1D LUC7L2 ZC3H13 KCTD10 SLTM LRRC59 ZC3H18 UPF3A MAP4K4 NIPBL	8.98e-07	1287	54	15	int:MECP2
Interaction	KLF15 interactions	NCOR1 NCOR2 GSE1 PRRC2C LRRC59 EIF3A NIPBL PRRC2B	9.78e-07	290	54	8	int:KLF15
Interaction	EXOSC4 interactions	SLTM GIGYF2 LRRC59 ZC3H18 UPF3B UPF3A PRRC2B	1.09e-06	202	54	7	int:EXOSC4
Interaction	WWTR1 interactions	NCOR1 RBM25 CALD1 NF2 PRRC2C ENAH AFDN MAP4K4 PRRC2B	1.64e-06	422	54	9	int:WWTR1
Interaction	SMG7 interactions	NCOR1 NCOR2 GSE1 RNF20 CDK11A RNF40 CEP97 PRRC2B	1.99e-06	319	54	8	int:SMG7
Interaction	SRPK2 interactions	GSE1 LUC7L3 PRRC2C LUC7L2 ZC3H13 SLTM AKAP13 ZC3H18 EIF3A UPF3B PRRC2B	2.54e-06	717	54	11	int:SRPK2
Interaction	ATXN1 interactions	NCOR1 NCOR2 RBM25 GSE1 PRRC2C LUC7L2 AFDN ZC3H18 EIF3A UBXN1 MAP4K4 HDGFL2 PRRC2B	2.60e-06	1039	54	13	int:ATXN1
Interaction	ZC3H18 interactions	CRACD RBM25 LUC7L3 PRRC2C LUC7L2 ZC3H13 SLTM CDK11A RNF40 LRRC59 ZC3H18 EIF3A	2.71e-06	877	54	12	int:ZC3H18
Interaction	PARN interactions	NCOR1 NCOR2 LUC7L2 RNF40 UPF3B UPF3A	2.74e-06	148	54	6	int:PARN
Interaction	NR2E1 interactions	ATN1 GSE1 UPF3B RERE	3.18e-06	38	54	4	int:NR2E1
Interaction	TERF2 interactions	ATN1 CALD1 MYO10 ZC3H13 SLTM RNF40 ZC3H18 HDGFL2	3.20e-06	340	54	8	int:TERF2
Interaction	YAP1 interactions	NCOR1 RBM25 ATN1 CALD1 WWC3 NF2 CSNK1D PRRC2C ENAH GIGYF2 AFDN LRRC59 EIF3A	4.62e-06	1095	54	13	int:YAP1
Interaction	DDX23 interactions	RBM25 LUC7L3 ZC3H13 SLTM CDK11A LRRC59 ZC3H18 ACBD3 HDGFL2	4.70e-06	480	54	9	int:DDX23
Interaction	KDM1A interactions	NCOR1 NCOR2 GSE1 NF2 LUC7L2 ITSN2 GAS8 GIGYF2 RNF40 TNFAIP1 RERE TNNT2	5.59e-06	941	54	12	int:KDM1A
Interaction	CBFA2T2 interactions	NCOR1 NCOR2 ATN1 RERE	6.32e-06	45	54	4	int:CBFA2T2
Interaction	CNOT2 interactions	NCOR1 NCOR2 CALD1 PRRC2C MINK1 PRRC2B	7.93e-06	178	54	6	int:CNOT2
Interaction	AR interactions	NCOR1 NCOR2 RBM25 ATN1 GSE1 ATRX LUC7L3 RNF20 RNF40 RERE NIPBL PRRC2B	9.55e-06	992	54	12	int:AR
Interaction	LUC7L3 interactions	NF2 LUC7L3 LUC7L2 KCTD10 ITSN2 ZC3H18	9.88e-06	185	54	6	int:LUC7L3
Interaction	PAX8 interactions	NCOR1 NCOR2 GSE1 NIPBL PRRC2B	1.18e-05	111	54	5	int:PAX8
Interaction	SSRP1 interactions	NCOR1 ATRX NF2 ZC3H13 SLTM ZC3H18 EIF3A UPF3A HDGFL2 NIPBL	1.19e-05	685	54	10	int:SSRP1
Interaction	SUPT5H interactions	NCOR1 NCOR2 GSE1 ATRX RNF20 RNF40 ZC3H18 NIPBL	1.21e-05	408	54	8	int:SUPT5H
Interaction	EXOSC1 interactions	NCOR1 KCTD10 GIGYF2 ZC3H18 PRRC2B	1.23e-05	112	54	5	int:EXOSC1
Interaction	DHX8 interactions	RBM25 LUC7L3 LUC7L2 ZC3H13 SLTM CDK11A ZC3H18	1.23e-05	292	54	7	int:DHX8
Interaction	IFI6 interactions	RBM25 ZC3H13 LEMD2 SLTM	1.32e-05	54	54	4	int:IFI6
Interaction	TNIP1 interactions	RBM25 CALD1 NF2 LUC7L3 MYO10 LUC7L2 KCTD10 SLTM CDK11A LRRC59 EIF3A UPF3B CEP97	1.44e-05	1217	54	13	int:TNIP1
Interaction	KCTD10 interactions	LUC7L3 KCTD10 ITSN2 TNFAIP1 UBXN1 CEP97	1.45e-05	198	54	6	int:KCTD10
Interaction	TBXT interactions	NCOR1 NCOR2 ATN1 GSE1 NIPBL	1.46e-05	116	54	5	int:TBXT
Interaction	ZRANB2 interactions	LUC7L3 LUC7L2 MINK1 ZC3H18 MAP4K4 HDGFL2	1.50e-05	199	54	6	int:ZRANB2
Interaction	C1D interactions	NCOR1 NCOR2 GIGYF2 ZC3H18	1.52e-05	56	54	4	int:C1D
Interaction	KCNA3 interactions	RBM25 CALD1 NF2 PRRC2C MINK1 GIGYF2 AFDN LRRC59 ZC3H18 RIMS1 MAP4K4	1.61e-05	871	54	11	int:KCNA3
Interaction	CAPZB interactions	CRACD CALD1 CSNK1D PRRC2C LUC7L2 MINK1 ENAH RNF20 RNF40 LRRC59 EIF3A NIPBL	1.67e-05	1049	54	12	int:CAPZB
Interaction	FEV interactions	NCOR1 NCOR2 GSE1 ATRX NIPBL PRRC2B	1.68e-05	203	54	6	int:FEV
Interaction	EFTUD2 interactions	LUC7L3 PRRC2C LUC7L2 RNF20 GIGYF2 AKAP13 RNF40 LRRC59 ZC3H18 EIF3A UPF3B ACBD3 HDGFL2 NIPBL	1.96e-05	1449	54	14	int:EFTUD2
Interaction	SUPT16H interactions	RBM25 ATRX NF2 ZC3H13 RNF20 CDK11A ZC3H18 CEP97	2.16e-05	442	54	8	int:SUPT16H
Interaction	KLHL20 interactions	RBM25 LUC7L2 MINK1 MAP3K13 HDGFL2 CEP97	2.38e-05	216	54	6	int:KLHL20
Interaction	HDAC4 interactions	NCOR1 NCOR2 ATRX NF2 PRRC2C LUC7L2 JDP2 GIGYF2 RNF40 PRRC2B	2.43e-05	744	54	10	int:HDAC4
Interaction	SNW1 interactions	NCOR1 NCOR2 ATRX LUC7L3 LUC7L2 KCTD10 ENAH JDP2 ZC3H18 NIPBL	2.52e-05	747	54	10	int:SNW1
Interaction	RPA4 interactions	NCOR1 RBM25 PRRC2C SLTM AFDN LRRC59 ZC3H18 CEP97	2.53e-05	452	54	8	int:RPA4
Interaction	PAX9 interactions	NCOR1 NCOR2 ATN1 GSE1 NIPBL	2.54e-05	130	54	5	int:PAX9
Interaction	NKAP interactions	RBM25 LUC7L2 CDK11A ZC3H18 UPF3B	2.73e-05	132	54	5	int:NKAP
Interaction	ERG interactions	NCOR1 NCOR2 GSE1 RERE NIPBL PRRC2B	2.85e-05	223	54	6	int:ERG
Interaction	HDAC1 interactions	NCOR1 NCOR2 RBM25 GSE1 ATRX NF2 LUC7L3 RNF20 JDP2 GIGYF2 RNF40 RERE	2.88e-05	1108	54	12	int:HDAC1
Interaction	EIF3B interactions	ATRX NF2 CDK11A ZC3H18 EIF3A UPF3B PRRC2B	3.10e-05	337	54	7	int:EIF3B
Interaction	CHD4 interactions	RBM25 GSE1 LUC7L3 PRRC2C LUC7L2 CDK11A GIGYF2 ZC3H18 EIF3A ACBD3 HDGFL2	3.19e-05	938	54	11	int:CHD4
Interaction	JPH4 interactions	MYO10 PRRC2C ZC3H18 PRRC2B	3.30e-05	68	54	4	int:JPH4
Interaction	GCM1 interactions	NCOR1 NCOR2 GSE1 PRRC2B	3.30e-05	68	54	4	int:GCM1
Interaction	EPS15L1 interactions	LUC7L2 ITSN1 ITSN2 CDK11A RNF40	3.38e-05	138	54	5	int:EPS15L1
Interaction	CALM3 interactions	CALD1 ATRX MYO10 MINK1 LRRC59 CEP97 IQCE	3.47e-05	343	54	7	int:CALM3
Interaction	EIF3A interactions	NCOR1 CALD1 PRRC2C ZC3H13 LRRC59 ZC3H18 EIF3A	4.31e-05	355	54	7	int:EIF3A
Interaction	PYHIN1 interactions	ZNF711 ATRX LUC7L3 GIGYF2 ZC3H18 HDGFL2 PRRC2B	4.55e-05	358	54	7	int:PYHIN1
Interaction	ITSN2 interactions	LUC7L3 ITSN1 KCTD10 ITSN2 RNF20	4.57e-05	147	54	5	int:ITSN2
Interaction	DOT1L interactions	RBM25 ATRX LUC7L3 LUC7L2 ZC3H13 SLTM GIGYF2 LRRC59 ZC3H18 EIF3A	4.85e-05	807	54	10	int:DOT1L
Interaction	ASF1A interactions	NCOR1 NCOR2 GSE1 CALD1 ATRX ZC3H13	5.27e-05	249	54	6	int:ASF1A
Interaction	TLE3 interactions	NCOR1 NCOR2 ATN1 GSE1 PRPF40B RERE NIPBL	6.20e-05	376	54	7	int:TLE3
Interaction	PSPC1 interactions	RBM25 NF2 CSNK1D PRRC2C LRRC59 ZC3H18 EIF3A PRRC2B	6.38e-05	515	54	8	int:PSPC1
Interaction	WBP11 interactions	ZC3H13 ITSN1 GIGYF2 ZC3H18 UPF3B	6.84e-05	160	54	5	int:WBP11
Interaction	LGR4 interactions	RBM25 PRRC2C GIGYF2 AFDN ZC3H18 EIF3A	6.98e-05	262	54	6	int:LGR4
Interaction	CDK9 interactions	RBM25 MYO10 CSNK1D PRRC2C ZC3H13 RNF20 SLTM RNF40 LRRC59	7.77e-05	685	54	9	int:CDK9
Interaction	SERBP1 interactions	RBM25 ATRX NF2 PRRC2C ZC3H13 RNF20 GIGYF2 LRRC59 EIF3A UPF3B UBXN1 ACBD3 PRRC2B	7.90e-05	1432	54	13	int:SERBP1
Interaction	CARD9 interactions	FAM50B GAS8 TNFAIP1 HDGFL2 IQCE	7.92e-05	165	54	5	int:CARD9
Interaction	E2F4 interactions	NCOR1 NCOR2 RBM25 LUC7L2 SLTM EIF3A UBXN1 PRRC2B	8.87e-05	540	54	8	int:E2F4
Interaction	CIT interactions	RBM25 NF2 LUC7L3 PRRC2C ZC3H13 KCTD10 CDK11A RNF40 LRRC59 EIF3A UPF3B HDGFL2 NIPBL	8.97e-05	1450	54	13	int:CIT
Interaction	TLX1 interactions	NCOR1 NCOR2 ATN1 GSE1 NIPBL	1.05e-04	175	54	5	int:TLX1
Interaction	SPEN interactions	NCOR1 NCOR2 RBM25 RNF40 ZC3H18	1.13e-04	178	54	5	int:SPEN
Interaction	LRPAP1 interactions	RBM25 CSNK1D LUC7L2 SLTM LRRC59	1.19e-04	180	54	5	int:LRPAP1
Interaction	LINC02910 interactions	ZC3H13 SLTM GIGYF2 PRRC2B	1.22e-04	95	54	4	int:LINC02910
Interaction	NUAK1 interactions	LRRC59 ZC3H18 EIF3A PRRC2B	1.27e-04	96	54	4	int:NUAK1
Interaction	RBBP4 interactions	NCOR1 GSE1 NF2 MYO10 LUC7L2 ITSN1 CDK11A ZC3H18	1.34e-04	573	54	8	int:RBBP4
Interaction	MFAP1 interactions	RBM25 ATRX PRPF40B CSNK1D GAS8 ZC3H18	1.34e-04	295	54	6	int:MFAP1
Interaction	BICD2 interactions	FAM50B CALD1 CSNK1D ITSN1 ENAH AFDN MAP4K4	1.35e-04	426	54	7	int:BICD2
Interaction	LHX3 interactions	NCOR1 NCOR2 GSE1 GAS8 NIPBL	1.36e-04	185	54	5	int:LHX3
Interaction	GATA3 interactions	NCOR1 NCOR2 GSE1 LEMD2 PRRC2B	1.43e-04	187	54	5	int:GATA3
Interaction	ATN1 interactions	ATN1 ATRX GIGYF2 RERE PRRC2B	1.43e-04	187	54	5	int:ATN1
Interaction	SIRT7 interactions	RBM25 PRRC2C ZC3H13 SLTM GIGYF2 AFDN ZC3H18 NIPBL PRRC2B	1.45e-04	744	54	9	int:SIRT7
Interaction	NFIA interactions	NCOR1 NCOR2 RBM25 GSE1 LUC7L3	1.46e-04	188	54	5	int:NFIA
Interaction	HNF1B interactions	NCOR1 NCOR2 GSE1 NIPBL PRRC2B	1.54e-04	190	54	5	int:HNF1B
Interaction	C1orf35 interactions	RBM25 NF2 CSNK1D LUC7L2 GAS8 ZC3H18	1.58e-04	304	54	6	int:C1orf35
Interaction	CNOT1 interactions	ATRX MYO10 MINK1 LRRC59 MAP4K4 PRRC2B	1.60e-04	305	54	6	int:CNOT1
Interaction	PML interactions	NCOR1 NCOR2 CALD1 ATRX CSNK1D RNF20 SLTM EIF3A TNFAIP1 CEP97	1.61e-04	933	54	10	int:PML
Interaction	CHD3 interactions	RBM25 GSE1 LUC7L3 PRRC2C LUC7L2 ZC3H13 LRRC59 ZC3H18 EIF3A	1.66e-04	757	54	9	int:CHD3
Interaction	SKA3 interactions	RBM25 ATRX LUC7L3 LEMD2 SLTM	1.69e-04	194	54	5	int:SKA3
Interaction	THRAP3 interactions	MYO10 LUC7L2 RNF40 LRRC59 ZC3H18 UPF3B NIPBL	1.72e-04	443	54	7	int:THRAP3
Interaction	KLF5 interactions	NCOR1 NCOR2 GSE1 NIPBL PRRC2B	1.73e-04	195	54	5	int:KLF5
Cytoband	1q42.12	ENAH ACBD3	2.21e-04	18	56	2	1q42.12
Cytoband	Ensembl 112 genes in cytogenetic band chr16q24	GSE1 GAS8 ZC3H18	6.28e-04	136	56	3	chr16q24
Cytoband	Xq21.1	ZNF711 ATRX	7.53e-04	33	56	2	Xq21.1
Cytoband	17q21.33	LUC7L3 LRRC59	1.16e-03	41	56	2	17q21.33
Cytoband	14q24.3	RBM25 JDP2	5.82e-03	93	56	2	14q24.3
GeneFamily	Zinc fingers MYND-type\|A-kinase anchoring proteins	NF2 AKAP13 ACBD3	2.35e-05	29	35	3	396
GeneFamily	GATA zinc finger domain containing\|Myb/SANT domain containing	NCOR1 NCOR2 RERE	1.46e-04	53	35	3	532
GeneFamily	X-linked mental retardation\|Angiotensin receptors	ZNF711 ATRX UPF3B	1.46e-04	53	35	3	103
GeneFamily	Pleckstrin homology domain containing\|Rho guanine nucleotide exchange factors\|C2 domain containing	ITSN1 ITSN2 AKAP13	2.80e-04	66	35	3	722
GeneFamily	Ataxins\|Trinucleotide repeat containing	NCOR2 GIGYF2	1.06e-03	25	35	2	775
GeneFamily	Zinc fingers CCCH-type	ZC3H13 ZC3H18	2.08e-03	35	35	2	73
GeneFamily	Pleckstrin homology domain containing\|Rho guanine nucleotide exchange factors\|C2 domain containing	ITSN1 ITSN2	2.20e-03	36	35	2	823
GeneFamily	Ankyrin repeat domain containing\|FERM domain containing	NF2 MYO10	4.21e-03	50	35	2	1293
GeneFamily	Pleckstrin homology domain containing\|Rho guanine nucleotide exchange factors\|C2 domain containing	MYO10 ITSN1 AKAP13	7.30e-03	206	35	3	682
GeneFamily	Basic leucine zipper proteins\|BTB domain containing	KCTD10 TNFAIP1	2.77e-02	134	35	2	861
Coexpression	LAKE_ADULT_KIDNEY_C3_PROXIMAL_TUBULE_EPITHELIAL_CELLS_S1_S2	RBM25 CALD1 LUC7L3 PRRC2C ZC3H13 AFDN AKAP13 MAP3K13 RERE	9.83e-10	221	56	9	M39222
Coexpression	DACOSTA_UV_RESPONSE_VIA_ERCC3_DN	NCOR2 GSE1 ATRX MYO10 PRRC2C ITSN1 SOCS5 ITSN2 GIGYF2 AKAP13 EIF3A ACBD3 NIPBL	2.26e-08	856	56	13	M4500
Coexpression	MENON_FETAL_KIDNEY_0_CAP_MESENCHYME_CELLS	RBM25 ATRX LUC7L3 ZC3H13 ENAH EIF3A	3.91e-08	90	56	6	M39250
Coexpression	GSE12198_LOW_IL2_STIM_NK_CELL_VS_HIGH_IL2_STIM_NK_CELL_UP	NCOR2 PRPF40B CSNK1D ITSN2 ZC3H18 ACBD3 NIPBL	2.29e-07	200	56	7	M7064
Coexpression	LAKE_ADULT_KIDNEY_C5_PROXIMAL_TUBULE_EPITHELIAL_CELLS_STRESS_INFLAM	NCOR1 RBM25 LUC7L3 PRRC2C ZC3H13 ITSN1 AKAP13 UPF3B MAP3K13	2.34e-07	417	56	9	M39224
Coexpression	MONNIER_POSTRADIATION_TUMOR_ESCAPE_UP	RBM25 LUC7L3 MYO10 SLTM LRRC59 ZC3H18 MAP4K4 NIPBL	2.38e-06	408	56	8	M11891
Coexpression	MONNIER_POSTRADIATION_TUMOR_ESCAPE_UP	RBM25 LUC7L3 MYO10 SLTM LRRC59 ZC3H18 MAP4K4 NIPBL	2.70e-06	415	56	8	MM1028
Coexpression	SHEN_SMARCA2_TARGETS_UP	NCOR1 ATRX LUC7L3 ZC3H13 ITSN2 SLTM UPF3B UPF3A	3.45e-06	429	56	8	M29
Coexpression	HOUNKPE_HOUSEKEEPING_GENES	RBM25 LUC7L3 CSNK1D LEMD2 RNF20 SLTM LRRC59 ZC3H18 EIF3A RERE UBXN1 ACBD3	3.71e-06	1129	56	12	M42508
Coexpression	GSE24671_CTRL_VS_SENDAI_VIRUS_INFECTED_MOUSE_SPLENOCYTES_DN	NCOR1 RBM25 PRRC2C SLTM ZC3H18 PRRC2B	4.20e-06	199	56	6	M9443
Coexpression	GSE17301_CTRL_VS_48H_ACD3_ACD28_IFNA5_STIM_CD8_TCELL_UP	NCOR2 ATRX AKAP13 RERE NIPBL CEP97	4.33e-06	200	56	6	M8050
Coexpression	HOUNKPE_HOUSEKEEPING_GENES	RBM25 LUC7L3 CSNK1D LEMD2 RNF20 SLTM LRRC59 ZC3H18 EIF3A RERE UBXN1 ACBD3	4.81e-06	1158	56	12	MM1338
Coexpression	GRYDER_PAX3FOXO1_ENHANCERS_IN_TADS	NCOR2 GSE1 ZC3H13 ITSN2 ENAH EIF3A RERE TNNT2 MAP4K4 CEP97 PRRC2B	7.92e-06	1009	56	11	M157
Coexpression	HAMAI_APOPTOSIS_VIA_TRAIL_UP	CALD1 LUC7L3 MYO10 ITSN2 ENAH RNF20 EIF3A UPF3A NIPBL	9.67e-06	656	56	9	M18979
Coexpression	TABULA_MURIS_SENIS_KIDNEY_KIDNEY_COLLECTING_DUCT_PRINCIPAL_CELL_AGEING	NCOR1 RBM25 ATRX PRRC2C ZC3H13 SLTM UBXN1	2.02e-05	394	56	7	MM3724
Coexpression	GABRIELY_MIR21_TARGETS	CALD1 ATRX ITSN2 ENAH NIPBL CEP97	3.49e-05	289	56	6	M2196
Coexpression	LASTOWSKA_NEUROBLASTOMA_COPY_NUMBER_UP	NCOR1 LUC7L3 MINK1 LRRC59 TNFAIP1	4.86e-05	186	56	5	M4203
Coexpression	DACOSTA_UV_RESPONSE_VIA_ERCC3_COMMON_DN	ATRX MYO10 PRRC2C ITSN1 SOCS5 ITSN2 GIGYF2	5.87e-05	466	56	7	M13522
Coexpression	GSE17301_IFNA2_VS_IFNA5_STIM_ACD3_ACD28_ACT_CD8_TCELL_UP	WWC3 PRRC2C CDK11A RERE PRRC2B	6.53e-05	198	56	5	M8036
Coexpression	GSE2585_CTEC_VS_THYMIC_MACROPHAGE_DN	NCOR1 GSE1 NF2 MYO10 RNF40	6.69e-05	199	56	5	M6264
Coexpression	GSE3982_EOSINOPHIL_VS_BASOPHIL_DN	NCOR1 GSE1 SLTM UPF3A MAP4K4	6.69e-05	199	56	5	M5414
Coexpression	GSE339_EX_VIVO_VS_IN_CULTURE_CD4CD8DN_DC_DN	NF2 KCTD10 SOCS5 LRRC59 MAP4K4	6.85e-05	200	56	5	M5135
Coexpression	GSE17721_CTRL_VS_CPG_2H_BMDC_UP	NCOR1 LUC7L3 CSNK1D TMEM191C UBXN1	6.85e-05	200	56	5	M3759
Coexpression	GSE17721_0.5H_VS_4H_PAM3CSK4_BMDC_DN	RBM25 MYO10 ITSN1 JDP2 TNNT2	6.85e-05	200	56	5	M4108
Coexpression	GSE7460_WT_VS_FOXP3_HET_ACT_WITH_TGFB_TCONV_UP	MYO10 ITSN1 KCTD10 LEMD2 PRRC2B	6.85e-05	200	56	5	M5711
Coexpression	ENK_UV_RESPONSE_KERATINOCYTE_DN	ATRX LUC7L3 MYO10 ITSN1 ITSN2 UPF3A ACBD3	7.16e-05	481	56	7	M3898
Coexpression	MURARO_PANCREAS_MESENCHYMAL_STROMAL_CELL	CALD1 MYO10 KCTD10 ENAH AKAP13 LRRC59 EIF3A MAP4K4	9.42e-05	681	56	8	M39175
Coexpression	MARTORIATI_MDM4_TARGETS_FETAL_LIVER_DN	RBM25 ATRX CSNK1D ENAH RNF20 LRRC59 TNFAIP1	1.15e-04	519	56	7	M3395
Coexpression	AIZARANI_LIVER_C31_KUPFFER_CELLS_5	RBM25 CALD1 LUC7L3 ZC3H13	1.28e-04	120	56	4	M39130
Coexpression	TABULA_MURIS_SENIS_SPLEEN_PROERYTHROBLAST_AGEING	RBM25 ATRX LUC7L3 PRRC2C LUC7L2 SLTM LRRC59 EIF3A UBXN1 NIPBL	1.38e-04	1144	56	10	MM3843
Coexpression	MARTORIATI_MDM4_TARGETS_FETAL_LIVER_DN	RBM25 ATRX CSNK1D ENAH RNF20 LRRC59 TNFAIP1	1.52e-04	543	56	7	MM997
Coexpression	AIZARANI_LIVER_C33_STELLATE_CELLS_2	ATN1 CALD1 LUC7L3 ENAH	1.54e-04	126	56	4	M39132
Coexpression	CHARAFE_BREAST_CANCER_LUMINAL_VS_BASAL_UP	CRACD GSE1 LUC7L3 CSNK1D PRRC2C IQCE	1.69e-04	385	56	6	M2840
Coexpression	FOURATI_BLOOD_TWINRIX_AGE_25_83YO_RESPONDERS_VS_POOR_RESPONDERS_0DY_DN	MYO10 CSNK1D PRRC2C ZC3H13 RNF20 JDP2 AFDN RERE	1.76e-04	746	56	8	M40863
Coexpression	NIKOLSKY_BREAST_CANCER_16Q24_AMPLICON	GSE1 GAS8 ZC3H18	1.90e-04	52	56	3	M12307
Coexpression	TABULA_MURIS_SENIS_SUBCUTANEOUS_ADIPOSE_TISSUE_EPITHELIAL_CELL_AGEING	ATN1 MYO10 ZC3H13 SOCS5 ENAH SLTM CDK11A	2.00e-04	568	56	7	MM3824
Coexpression	XIE_TRASTUZUMAB_CARDIOTOXICITY_MMU_MIR_10A_5P_GENES	NCOR2 ITSN1	2.44e-04	11	56	2	MM17491
Coexpression	ONKEN_UVEAL_MELANOMA_UP	NCOR1 RBM25 WWC3 LUC7L3 PRRC2C LUC7L2 MINK1 AKAP13	2.60e-04	790	56	8	M12490
Coexpression	LAKE_ADULT_KIDNEY_C20_COLLECTING_DUCT_INTERCALATED_CELLS_TYPE_A_CORTEX	RBM25 LUC7L3 MYO10 RERE	3.16e-04	152	56	4	M39239
Coexpression	BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_UP	RBM25 GSE1 ITSN2 EIF3A UPF3B ACBD3 NIPBL PRRC2B	3.39e-04	822	56	8	M6782
Coexpression	GRYDER_PAX3FOXO1_TOP_ENHANCERS	NCOR2 GSE1 ITSN2 ENAH RERE TNNT2	3.50e-04	441	56	6	M172
Coexpression	LAKE_ADULT_KIDNEY_C4_PROXIMAL_TUBULE_EPITHELIAL_CELLS_S2	CALD1 ITSN1 AKAP13 RERE	5.50e-04	176	56	4	M39223
Coexpression	BRUINS_UVC_RESPONSE_EARLY_LATE	CALD1 ATRX GAS8 EIF3A NIPBL	5.70e-04	316	56	5	M2248
Coexpression	GSE27241_WT_VS_RORGT_KO_TH17_POLARIZED_CD4_TCELL_TREATED_WITH_DIGOXIN_UP	NCOR1 MYO10 PRRC2C MAP4K4	5.98e-04	180	56	4	M8239
Coexpression	BRUINS_UVC_RESPONSE_EARLY_LATE	CALD1 ATRX GAS8 EIF3A NIPBL	6.03e-04	320	56	5	MM1063
Coexpression	HUANG_DASATINIB_SENSITIVITY_UP	CALD1 MYO10 SOCS5	6.75e-04	80	56	3	M3015
Coexpression	XIE_TRASTUZUMAB_CARDIOTOXICITY_MMU_MIR_345_5P_GENES	NCOR2 ITSN1 MAP3K13	6.75e-04	80	56	3	MM17502
Coexpression	DIAZ_CHRONIC_MYELOGENOUS_LEUKEMIA_UP	NCOR1 ATRX LUC7L3 CSNK1D EIF3A UPF3B TNFAIP1 UPF3A MAP4K4 ACBD3	6.84e-04	1399	56	10	M535
Coexpression	MILI_PSEUDOPODIA_CHEMOTAXIS_UP	KCTD10 EIF3A UPF3A	7.79e-04	84	56	3	M15130
Coexpression	GSE2706_2H_VS_8H_LPS_STIM_DC_DN	CRACD AFDN MAP3K13 MAP4K4	7.91e-04	194	56	4	M4733
Coexpression	NAKAYA_PLASMACYTOID_DENDRITIC_CELL_FLUARIX_FLUVIRIN_AGE_18_50YO_7DY_DN	NCOR2 WWC3 LUC7L2 SOCS5	8.22e-04	196	56	4	M41105
Coexpression	GSE29617_CTRL_VS_DAY3_TIV_FLU_VACCINE_PBMC_2008_UP	RBM25 PRRC2C LEMD2 GIGYF2	8.22e-04	196	56	4	M4928
Coexpression	GSE46606_IRF4_KO_VS_WT_CD40L_IL2_IL5_3DAY_STIMULATED_BCELL_UP	NCOR2 GSE1 AFDN MAP3K13	8.22e-04	196	56	4	M9821
Coexpression	MILI_PSEUDOPODIA_CHEMOTAXIS_UP	KCTD10 EIF3A UPF3A	8.34e-04	86	56	3	MM825
Coexpression	TABULA_MURIS_SENIS_AORTA_FIBROBLAST_OF_CARDIAC_TISSUE_AGEING	RBM25 ATN1 LUC7L3 AKAP13 ZC3H18 NIPBL PRRC2B	8.46e-04	723	56	7	MM3672
Coexpression	GSE2706_UNSTIM_VS_8H_LPS_DC_DN	CRACD MYO10 AFDN MAP4K4	8.54e-04	198	56	4	M4701
Coexpression	MURARO_PANCREAS_BETA_CELL	CRACD NCOR2 GSE1 ATRX GIGYF2 RERE UBXN1 PRRC2B	8.55e-04	946	56	8	M39169
Coexpression	MILI_PSEUDOPODIA_HAPTOTAXIS_UP	NCOR1 RBM25 ATRX KCTD10 SLTM NIPBL	8.55e-04	523	56	6	M12707
Coexpression	GSE369_IFNG_KO_VS_WT_LIVER_UP	GSE1 ATRX NIPBL CEP97	8.70e-04	199	56	4	M5970
Coexpression	GSE22025_PROGESTERONE_VS_TGFB1_AND_PROGESTERONE_TREATED_CD4_TCELL_UP	RBM25 ATRX CSNK1D ZC3H13	8.70e-04	199	56	4	M8381
Coexpression	GSE14769_40MIN_VS_360MIN_LPS_BMDM_DN	MYO10 LEMD2 AKAP13 ACBD3	8.70e-04	199	56	4	M3517
Coexpression	GSE17721_CTRL_VS_POLYIC_8H_BMDC_UP	NCOR2 RERE UBXN1 MAP4K4	8.70e-04	199	56	4	M3717
Coexpression	GSE45365_WT_VS_IFNAR_KO_CD8A_DC_MCMV_INFECTION_UP	LUC7L2 SOCS5 AFDN RERE	8.70e-04	199	56	4	M9964
Coexpression	GSE3982_MAST_CELL_VS_TH1_UP	GSE1 SOCS5 SLTM ACBD3	8.70e-04	199	56	4	M5453
Coexpression	GSE31082_DN_VS_CD8_SP_THYMOCYTE_DN	NCOR1 RERE TNNT2 IQCE	8.86e-04	200	56	4	M5063
Coexpression	GSE29618_PRE_VS_DAY7_POST_TIV_FLU_VACCINE_PDC_DN	GSE1 ATRX EIF3A TNFAIP1	8.86e-04	200	56	4	M5005
Coexpression	GSE15330_HSC_VS_GRANULOCYTE_MONOCYTE_PROGENITOR_UP	NCOR1 PRPF40B CSNK1D NIPBL	8.86e-04	200	56	4	M7060
Coexpression	GSE15330_WT_VS_IKAROS_KO_LYMPHOID_MULTIPOTENT_PROGENITOR_DN	RBM25 LEMD2 EIF3A ACBD3	8.86e-04	200	56	4	M7058
Coexpression	GSE3920_UNTREATED_VS_IFNB_TREATED_ENDOTHELIAL_CELL_UP	ITSN1 CCDC81 RERE MAP4K4	8.86e-04	200	56	4	M6686
Coexpression	GSE5679_CTRL_VS_RARA_AGONIST_AM580_TREATED_DC_DN	ATRX LEMD2 TMEM191C TNFAIP1	8.86e-04	200	56	4	M6556
Coexpression	GSE24814_STAT5_KO_VS_WT_PRE_BCELL_DN	ATRX PRRC2C GIGYF2 RERE	8.86e-04	200	56	4	M8427
Coexpression	GSE16522_MEMORY_VS_NAIVE_CD8_TCELL_DN	CRACD LUC7L3 TMEM191C SLTM	8.86e-04	200	56	4	M3659
Coexpression	GSE17721_CTRL_VS_LPS_6H_BMDC_UP	NCOR1 UPF3B RERE UBXN1	8.86e-04	200	56	4	M3691
Coexpression	GSE40068_BCL6_POS_VS_NEG_CXCR5_POS_TFH_DN	ATN1 PRPF40B RERE MAP4K4	8.86e-04	200	56	4	M9260
Coexpression	GSE7460_FOXP3_MUT_VS_WT_ACT_WITH_TGFB_TCONV_DN	RERE MAP4K4 CEP97 PRRC2B	8.86e-04	200	56	4	M5705
Coexpression	GSE21546_SAP1A_KO_VS_SAP1A_KO_AND_ELK1_KO_ANTI_CD3_STIM_DP_THYMOCYTES_UP	CRACD LUC7L2 RNF20 UBXN1	8.86e-04	200	56	4	M7525
Coexpression	GSE40274_GATA1_VS_FOXP3_AND_GATA1_TRANSDUCED_ACTIVATED_CD4_TCELL_DN	CSNK1D JDP2 AFDN UPF3B	8.86e-04	200	56	4	M9165
Coexpression	GSE17721_LPS_VS_POLYIC_4H_BMDC_UP	KCTD10 JDP2 LRRC59 ACBD3	8.86e-04	200	56	4	M3803
Coexpression	RICKMAN_METASTASIS_UP	ZNF711 RBM25 ATRX GIGYF2 UPF3B	9.02e-04	350	56	5	M9752
Coexpression	MILI_PSEUDOPODIA_HAPTOTAXIS_UP	NCOR1 RBM25 ATRX KCTD10 SLTM NIPBL	9.52e-04	534	56	6	MM1054
Coexpression	MENON_FETAL_KIDNEY_4_PODOCYTES	CALD1 LUC7L3 PRRC2C TNNT2	9.89e-04	206	56	4	M39254
Coexpression	STARK_PREFRONTAL_CORTEX_22Q11_DELETION_UP	RBM25 ATN1 MINK1 PRRC2B	9.89e-04	206	56	4	M2817
Coexpression	STARK_PREFRONTAL_CORTEX_22Q11_DELETION_UP	RBM25 ATN1 MINK1 PRRC2B	1.02e-03	208	56	4	MM581
Coexpression	DE_YY1_TARGETS_DN	NCOR1 CALD1 SOCS5	1.05e-03	93	56	3	M3278
Coexpression	ZWANG_CLASS_1_TRANSIENTLY_INDUCED_BY_EGF	CALD1 KCTD10 SOCS5 AFDN AKAP13 TNFAIP1	1.11e-03	550	56	6	M2611
Coexpression	KIM_WT1_TARGETS_12HR_DN	RBM25 CALD1 NF2 TNFAIP1	1.18e-03	216	56	4	M4987
Coexpression	HOEBEKE_LYMPHOID_STEM_CELL_UP	NCOR2 ITSN2 RERE	1.18e-03	97	56	3	M14698
CoexpressionAtlas	FacebaseRNAseq_e10.5_Medial Nasal Eminence_top-relative-expression-ranked_1000_k-means-cluster#4	RBM25 CALD1 ATRX LUC7L3 ITSN2 ENAH SLTM EIF3A NIPBL	7.96e-08	298	56	9	Facebase_RNAseq_e10.5_Medial Nasal Eminence_1000_K4
CoexpressionAtlas	FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_2500_k-means-cluster#5	CRACD NCOR1 ATN1 ATRX LUC7L3 MYO10 ENAH SLTM EIF3A UPF3B UPF3A RERE NIPBL	1.83e-07	831	56	13	Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_2500_K5
CoexpressionAtlas	facebase_RNAseq_e10.5_NeuroEpith_central_2500_K4	ZNF711 CRACD RBM25 ATRX LUC7L3 PRPF40B MYO10 ZC3H13 RNF20 SLTM EIF3A UPF3B RIMS1 RERE NIPBL CEP97	2.93e-07	1370	56	16	facebase_RNAseq_e10.5_NeuroEpith_central_2500_K4
CoexpressionAtlas	DevelopingKidney_e15.5_anlage of loop of Henle_emap-31283_k-means-cluster#3_top-relative-expression-ranked_500	NCOR1 ATRX MYO10 PRRC2C GIGYF2 AKAP13 TNNT2	9.61e-07	201	56	7	gudmap_developingKidney_e15.5_500_k3
CoexpressionAtlas	DevelopingGonad_e11.5_ovary + mesonephros_emap-3226_top-relative-expression-ranked_1000	ZNF711 RBM25 GSE1 CALD1 ATRX PRRC2C LUC7L2 ZC3H13 ITSN1 GIGYF2 EIF3A CEP97	1.11e-06	815	56	12	gudmap_developingGonad_e11.5_ovary + mesonephros_1000
CoexpressionAtlas	FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_1000_k-means-cluster#2	NCOR1 ATRX LUC7L3 ENAH SLTM EIF3A UPF3B NIPBL	1.49e-06	311	56	8	Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_1000_K2
CoexpressionAtlas	FacebaseRNAseq_e10.5_Maxillary Arch_top-relative-expression-ranked_2500_k-means-cluster#5	ZNF711 ATRX LUC7L3 CSNK1D ENAH RNF20 SLTM EIF3A ACBD3 NIPBL	5.05e-06	629	56	10	Facebase_RNAseq_e10.5_Maxillary Arch_2500_K5
CoexpressionAtlas	facebase_RNAseq_e10.5_Emin_MedNas_2500_K1	ZNF711 CRACD RBM25 ATRX LUC7L3 ZC3H13 ENAH SLTM EIF3A UPF3B NIPBL CEP97	1.64e-05	1060	56	12	facebase_RNAseq_e10.5_Emin_MedNas_2500_K1
CoexpressionAtlas	facebase_RNAseq_e10.5_Emin_LatNas_2500_K3	ZNF711 CRACD RBM25 ATRX LUC7L3 MYO10 ZC3H13 ENAH RNF20 SLTM EIF3A UPF3B NIPBL	1.79e-05	1257	56	13	facebase_RNAseq_e10.5_Emin_LatNas_2500_K3
CoexpressionAtlas	DevelopingGonad_e11.5_ovary + mesonephros_emap-3226_k-means-cluster#2_top-relative-expression-ranked_1000	ZNF711 ATRX PRRC2C ZC3H13 ITSN1 GIGYF2 CEP97	2.16e-05	323	56	7	gudmap_developingGonad_e11.5_ovary + mesonephros_k2_1000
CoexpressionAtlas	FacebaseRNAseq_e10.5_Medial Nasal Eminence_top-relative-expression-ranked_2500_k-means-cluster#4	RBM25 CALD1 ATRX LUC7L3 ITSN2 ENAH SLTM AKAP13 EIF3A NIPBL	2.17e-05	744	56	10	Facebase_RNAseq_e10.5_Medial Nasal Eminence_2500_K4
CoexpressionAtlas	DevelopingKidney_e15.5_ureter tip_flank cortic collct_emap-27752_k-means-cluster#5_top-relative-expression-ranked_1000	ATRX NF2 LUC7L3 MYO10 PRRC2C ENAH GIGYF2	2.94e-05	339	56	7	gudmap_developingKidney_e15.5_ureter tip_flank cortic collct_1000_k5
CoexpressionAtlas	FacebaseRNAseq_e8.5_Floor Plate_top-relative-expression-ranked_2500_k-means-cluster#1	RBM25 ATRX PRRC2C SLTM GIGYF2 EIF3A MAP4K4 NIPBL	2.99e-05	469	56	8	Facebase_RNAseq_e8.5_Floor Plate_2500_K1
CoexpressionAtlas	DevelopingGonad_e16.5_epididymis_emap-29702_top-relative-expression-ranked_1000	ZNF711 RBM25 CALD1 ATRX LUC7L3 PRRC2C LUC7L2 ZC3H13 GIGYF2 EIF3A	3.62e-05	790	56	10	gudmap_developingGonad_e16.5_epididymis_1000
CoexpressionAtlas	DevelopingGonad_e14.5_ epididymis_emap-29141_top-relative-expression-ranked_1000	ZNF711 RBM25 CALD1 ATRX LUC7L3 PRRC2C LUC7L2 ZC3H13 GIGYF2 EIF3A	4.07e-05	801	56	10	gudmap_developingGonad_e14.5_ epididymis_1000
CoexpressionAtlas	DevelopingGonad_e12.5_ovary_emap-28876_top-relative-expression-ranked_1000	ZNF711 RBM25 CALD1 ATRX LUC7L3 PRRC2C LUC7L2 ZC3H13 GIGYF2 EIF3A	4.20e-05	804	56	10	gudmap_developingGonad_e12.5_ovary_1000
CoexpressionAtlas	FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_1000	CRACD NCOR1 ATRX LUC7L3 MYO10 ENAH SLTM EIF3A UPF3B NIPBL CEP97	4.59e-05	989	56	11	Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_1000
CoexpressionAtlas	DevelopingKidney_e15.5_anlage of loop of Henle_emap-31283_k-means-cluster#3_top-relative-expression-ranked_1000	NCOR1 ATRX NF2 MYO10 PRRC2C ENAH AKAP13	5.97e-05	379	56	7	gudmap_developingKidney_e15.5_1000_k3
CoexpressionAtlas	facebase_RNAseq_e10.5_Emin_LatNas_2500	ZNF711 CRACD RBM25 ATRX LUC7L3 MYO10 ZC3H13 ENAH RNF20 SLTM EIF3A UPF3B NIPBL	8.41e-05	1459	56	13	facebase_RNAseq_e10.5_Emin_LatNas_2500
CoexpressionAtlas	DevelopingKidney_e15.5_anlage of loop of Henle_emap-31283_top-relative-expression-ranked_500	NCOR1 ATRX MYO10 PRRC2C GIGYF2 AKAP13 TNNT2	8.63e-05	402	56	7	gudmap_developingKidney_e15.5_anlage of loop of Henle_500
CoexpressionAtlas	DevelopingGonad_e12.5_epididymis_emap-29139_top-relative-expression-ranked_500	RBM25 CALD1 ATRX PRRC2C LUC7L2 ZC3H13 EIF3A	8.76e-05	403	56	7	gudmap_developingGonad_e12.5_epididymis_500
CoexpressionAtlas	DevelopingGonad_e11.5_ovary + mesonephros_emap-3226_k-means-cluster#4_top-relative-expression-ranked_500	ZNF711 ATRX ZC3H13 GIGYF2 CEP97	9.00e-05	172	56	5	gudmap_developingGonad_e11.5_ovary + mesonephros_k4_500
CoexpressionAtlas	DevelopingGonad_e12.5_ovary_emap-28876_top-relative-expression-ranked_500	ZNF711 RBM25 ATRX LUC7L2 ZC3H13 GIGYF2 EIF3A	9.61e-05	409	56	7	gudmap_developingGonad_e12.5_ovary_500
CoexpressionAtlas	DevelopingGonad_e11.5_ovary + mesonephros_emap-3226_top-relative-expression-ranked_500	ZNF711 CALD1 ATRX LUC7L2 ZC3H13 GIGYF2 CEP97	1.08e-04	417	56	7	gudmap_developingGonad_e11.5_ovary + mesonephros_500
CoexpressionAtlas	FacebaseRNAseq_e9.5_Mandibular Arch_top-relative-expression-ranked_2500_k-means-cluster#2	ZNF711 ATRX CSNK1D ZC3H13 ENAH GAS8 RNF20 ACBD3	1.09e-04	564	56	8	Facebase_RNAseq_e9.5_Mandibular Arch_2500_K2
CoexpressionAtlas	FacebaseRNAseq_e10.5_Maxillary Arch_top-relative-expression-ranked_1000_k-means-cluster#3	ZNF711 ATRX LUC7L3 ENAH SLTM EIF3A NIPBL	1.35e-04	432	56	7	Facebase_RNAseq_e10.5_Maxillary Arch_1000_K3
CoexpressionAtlas	DevelopingGonad_e14.5_ ovary_emap-6699_k-means-cluster#1_top-relative-expression-ranked_500	ZNF711 ATRX ZC3H13 GIGYF2	1.46e-04	101	56	4	gudmap_developingGonad_e14.5_ ovary_500_k1
CoexpressionAtlas	FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_500_k-means-cluster#3	ATRX LUC7L3 SLTM EIF3A NIPBL	1.51e-04	192	56	5	Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_500_K3
CoexpressionAtlas	FacebaseRNAseq_e10.5_Neural Epithelium Overlying Medial Eminence_top-relative-expression-ranked_2500_k-means-cluster#4	ZNF711 CRACD ATRX LUC7L3 CSNK1D ENAH RNF20 ACBD3	1.57e-04	595	56	8	Facebase_RNAseq_e10.5_Neural Epithelium Overlying Medial Eminence_2500_K4
CoexpressionAtlas	FacebaseRNAseq_e10.5_Medial Nasal Eminence_top-relative-expression-ranked_1000	RBM25 CALD1 ATRX LUC7L3 ITSN2 ENAH SLTM EIF3A TNNT2 NIPBL	2.14e-04	979	56	10	Facebase_RNAseq_e10.5_Medial Nasal Eminence_1000
CoexpressionAtlas	DevelopingGonad_e16.5_ovary_emap-9563_top-relative-expression-ranked_1000	ZNF711 RBM25 ATRX LUC7L3 PRRC2C LUC7L2 ZC3H13 GIGYF2 EIF3A	2.16e-04	795	56	9	gudmap_developingGonad_e16.5_ovary_1000
CoexpressionAtlas	DevelopingKidney_e15.5_anlage of loop of Henle_emap-31283_top-relative-expression-ranked_1000	NCOR1 ATRX NF2 MYO10 PRRC2C ENAH GIGYF2 AKAP13 TNNT2	2.16e-04	795	56	9	gudmap_developingKidney_e15.5_anlage of loop of Henle_1000
CoexpressionAtlas	DevelopingGonad_P2_epididymis_emap-30199_top-relative-expression-ranked_1000	RBM25 CALD1 ATRX LUC7L3 PRRC2C LUC7L2 ZC3H13 EIF3A TNNT2	2.20e-04	797	56	9	gudmap_developingGonad_P2_epididymis_1000
CoexpressionAtlas	DevelopingGonad_e18.5_epididymis_emap-13166_top-relative-expression-ranked_1000	ZNF711 RBM25 CALD1 ATRX LUC7L3 PRRC2C LUC7L2 ZC3H13 EIF3A	2.24e-04	799	56	9	gudmap_developingGonad_e18.5_epididymis_1000
CoexpressionAtlas	DevelopingGonad_e12.5_epididymis_emap-29139_top-relative-expression-ranked_1000	RBM25 CALD1 ATRX LUC7L3 MYO10 PRRC2C LUC7L2 ZC3H13 EIF3A	2.39e-04	806	56	9	gudmap_developingGonad_e12.5_epididymis_1000
CoexpressionAtlas	facebase_RNAseq_e10.5_Emin_MedNas_2500	ZNF711 CRACD RBM25 ATRX LUC7L3 ZC3H13 ENAH SLTM EIF3A UPF3B NIPBL CEP97	2.61e-04	1414	56	12	facebase_RNAseq_e10.5_Emin_MedNas_2500
CoexpressionAtlas	DevelopingGonad_e16.5_epididymis_emap-29702_k-means-cluster#4_top-relative-expression-ranked_1000	ZNF711 ATRX LUC7L2 GIGYF2	3.52e-04	127	56	4	gudmap_developingGonad_e16.5_epididymis_1000_k4
CoexpressionAtlas	facebase_RNAseq_e10.5_MaxArch_2500_K3	ZNF711 CRACD RBM25 CALD1 ATRX LUC7L3 ENAH SLTM EIF3A UPF3B NIPBL	3.67e-04	1252	56	11	facebase_RNAseq_e10.5_MaxArch_2500_K3
CoexpressionAtlas	DevelopingGonad_P2_epididymis_emap-30199_top-relative-expression-ranked_500	ATRX PRRC2C LUC7L2 ZC3H13 EIF3A TNNT2	5.91e-04	395	56	6	gudmap_developingGonad_P2_epididymis_500
CoexpressionAtlas	DevelopingKidney_e15.5_Cap mesenchyme_emap-27738_k-means-cluster#5_top-relative-expression-ranked_1000	ATRX NF2 MYO10 AKAP13	5.97e-04	146	56	4	gudmap_developingKidney_e15.5_Cap mesenchyme_1000_k5
CoexpressionAtlas	FacebaseRNAseq_e8.5_Floor Plate_top-relative-expression-ranked_1000_k-means-cluster#1	RBM25 PRRC2C SLTM GIGYF2 NIPBL	5.97e-04	259	56	5	Facebase_RNAseq_e8.5_Floor Plate_1000_K1
CoexpressionAtlas	DevelopingKidney_e15.5_Medullary collecting duct_emap-28063_k-means-cluster#4_top-relative-expression-ranked_1000	NF2 LUC7L3 MYO10 PRRC2C ACBD3	6.18e-04	261	56	5	gudmap_developingKidney_e15.5_Medullary collecting duct_1000_k4
CoexpressionAtlas	DevelopingGonad_e18.5_epididymis_emap-13166_top-relative-expression-ranked_500	CALD1 ATRX PRRC2C LUC7L2 ZC3H13 EIF3A	6.65e-04	404	56	6	gudmap_developingGonad_e18.5_epididymis_500
CoexpressionAtlas	DevelopingGonad_e16.5_epididymis_emap-29702_top-relative-expression-ranked_500	CALD1 ATRX PRRC2C LUC7L2 ZC3H13 EIF3A	6.82e-04	406	56	6	gudmap_developingGonad_e16.5_epididymis_500
CoexpressionAtlas	DevelopingLowerUrinaryTract_P1_ureter_emap-30363_k-means-cluster#3_top-relative-expression-ranked_100	RIMS1 TNNT2	7.02e-04	15	56	2	gudmap_developingLowerUrinaryTract_P1_ureter_100_k3
CoexpressionAtlas	DevelopingGonad_e18.5_epididymis_emap-13166_k-means-cluster#3_top-relative-expression-ranked_500	ATRX LUC7L2 ZC3H13	7.38e-04	67	56	3	gudmap_developingGonad_e18.5_epididymis_500_k3
CoexpressionAtlas	DevelopingGonad_e14.5_ epididymis_emap-29141_k-means-cluster#3_top-relative-expression-ranked_1000	ZNF711 ATRX LUC7L3 ZC3H13 GIGYF2	7.83e-04	275	56	5	gudmap_developingGonad_e14.5_ epididymis_1000_k3
CoexpressionAtlas	FacebaseRNAseq_e10.5_Lateral Nasal Eminence_top-relative-expression-ranked_2500_k-means-cluster#1	ATN1 ATRX ITSN2 ENAH UPF3A RERE ACBD3 NIPBL	9.54e-04	780	56	8	Facebase_RNAseq_e10.5_Lateral Nasal Eminence_2500_K1
CoexpressionAtlas	DevelopingGonad_e14.5_ epididymis_emap-29141_top-relative-expression-ranked_200	CALD1 ATRX LUC7L2 ZC3H13	9.86e-04	167	56	4	gudmap_developingGonad_e14.5_ epididymis_200
CoexpressionAtlas	FacebaseRNAseq_e10.5_Lateral Nasal Eminence_top-relative-expression-ranked_1000_k-means-cluster#3	ATRX ENAH UPF3A ACBD3 NIPBL	1.01e-03	291	56	5	Facebase_RNAseq_e10.5_Lateral Nasal Eminence_1000_K3
CoexpressionAtlas	DevelopingGonad_e14.5_ epididymis_emap-29141_k-means-cluster#1_top-relative-expression-ranked_200	CALD1 LUC7L2	1.13e-03	19	56	2	gudmap_developingGonad_e14.5_ epididymis_200_k1
CoexpressionAtlas	DevelopingKidney_e14.5 whole kidney - Wnt4 KO_emap-6674_k-means-cluster#2_top-relative-expression-ranked_100	CALD1 TNNT2	1.13e-03	19	56	2	gudmap_developingKidney_e14.5 whole kidney - Wnt4 KO_100_k2
CoexpressionAtlas	DevelopingLowerUrinaryTract_adult_bladder_emap-29457_k-means-cluster#4_top-relative-expression-ranked_100	RIMS1 TNNT2	1.13e-03	19	56	2	gudmap_developingLowerUrinaryTract_adult_bladder_100_k4
CoexpressionAtlas	DevelopingGonad_e12.5_testes_emap-29069_top-relative-expression-ranked_100	CALD1 ATRX LUC7L2	1.33e-03	82	56	3	gudmap_developingGonad_e12.5_testes_100
CoexpressionAtlas	DevelopingGonad_e11.5_testes_emap-3226_top-relative-expression-ranked_1000	RBM25 GSE1 CALD1 ATRX PRRC2C LUC7L2 ITSN1 EIF3A	1.57e-03	843	56	8	gudmap_developingGonad_e11.5_testes_1000
CoexpressionAtlas	DevelopingGonad_e11.5_testes and mesonephros_emap-3226_top-relative-expression-ranked_1000	RBM25 GSE1 CALD1 ATRX CSNK1D LUC7L2 ITSN1 EIF3A	1.58e-03	844	56	8	gudmap_developingGonad_e11.5_testes and mesonephros_1000
CoexpressionAtlas	FacebaseRNAseq_e10.5_Lateral Nasal Eminence_top-relative-expression-ranked_500_k-means-cluster#4	ATRX ENAH ACBD3 NIPBL	1.65e-03	192	56	4	Facebase_RNAseq_e10.5_Lateral Nasal Eminence_500_K4
CoexpressionAtlas	DevelopingKidney_e14.5 whole kidney - Wnt4 KO_emap-6674_k-means-cluster#1_top-relative-expression-ranked_500	CALD1 LUC7L2 TNNT2	1.79e-03	91	56	3	gudmap_developingKidney_e14.5 whole kidney - Wnt4 KO_500_k1
CoexpressionAtlas	e9.5_NeuroEpith_OverFaceMesench_top-relative-expression-ranked_500_5	CRACD PRRC2B	1.82e-03	24	56	2	Facebase_ST1_e9.5_NeuroEpith_OverFaceMesench_500_5
CoexpressionAtlas	FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_500	ATRX LUC7L3 MYO10 SLTM EIF3A NIPBL	1.94e-03	498	56	6	Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_500
CoexpressionAtlas	DevelopingGonad_e18.5_ovary_emap-12283_k-means-cluster#3_top-relative-expression-ranked_500	ZNF711 ATRX ZC3H13	2.15e-03	97	56	3	gudmap_developingGonad_e18.5_ovary_500_k3
CoexpressionAtlas	DevelopingLowerUrinaryTract_P1_ureter_emap-30363_k-means-cluster#4_top-relative-expression-ranked_200	RIMS1 TNNT2	2.30e-03	27	56	2	gudmap_developingLowerUrinaryTract_P1_ureter_200_k4
CoexpressionAtlas	DevelopingLowerUrinaryTract_P1_bladder_J_emap-30374_k-means-cluster#4_top-relative-expression-ranked_500	CALD1 RIMS1 TNNT2	2.62e-03	104	56	3	gudmap_developingLowerUrinaryTract_P1_bladder_J_500_k4
CoexpressionAtlas	DevelopingLowerUrinaryTract_e14.5_ bladder_emap-30872_k-means-cluster#3_top-relative-expression-ranked_200	CALD1 TNNT2	2.65e-03	29	56	2	gudmap_developingLowerUrinaryTract_e14.5_ bladder_200_k3
CoexpressionAtlas	FacebaseRNAseq_e8.5_Hind Brain Neural Epithelium_top-relative-expression-ranked_2500_k-means-cluster#3	RBM25 PRRC2C SLTM GIGYF2 EIF3A NIPBL	2.70e-03	532	56	6	Facebase_RNAseq_e8.5_Hind Brain Neural Epithelium_2500_K3
ToppCell	droplet-Tongue-nan\|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	NCOR1 RBM25 ATRX LUC7L3 PRRC2C SLTM EIF3A NIPBL	9.58e-11	188	56	8	d62cc37e86b7b186e53aeb7f421c4e5ee28f23bd
ToppCell	H1299-infected-SARSCoV2\|infected / Cell line, Condition and Strain	RBM25 ATRX LUC7L3 PRRC2C ZC3H13 SLTM EIF3A UPF3B	1.39e-10	197	56	8	0fa3e4cf93e77d78b1f97b906c5b13ca741ae17e
ToppCell	H1299-infected\|H1299 / Cell line, Condition and Strain	NCOR1 RBM25 LUC7L3 PRRC2C SLTM EIF3A PRRC2B	4.49e-09	192	56	7	9cf8049bdc3e0f81ce69042beac72b08d8f38b4e
ToppCell	mild\|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class	RBM25 ATRX PRRC2C ITSN2 AKAP13 EIF3A NIPBL	5.95e-09	200	56	7	12f1685ce8f218433068e090c9d839cd5a1910bf
ToppCell	droplet-Marrow-nan-3m\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	NCOR1 ATRX PRRC2C ITSN2 EIF3A NIPBL	1.18e-07	184	56	6	1154a5ad7b8512272b7476f949ddac350910bfb7
ToppCell	human_hepatoblastoma\|World / Sample and Cell Type and Tumor Cluster (all cells)	LUC7L3 PRRC2C AFDN RERE MAP4K4 NIPBL	1.57e-07	193	56	6	e6a688bc834f845ff64dae1be64f073eec5091a1
ToppCell	(03)_KRT6B+-(2)_GFP_FOXI1\|(03)_KRT6B+ / shred by cell type by condition	NCOR1 ATRX PRRC2C ZC3H13 ITSN2 NIPBL	1.88e-07	199	56	6	c425e7975f492ed5cfcca022248adb627e1d27d4
ToppCell	(01)_IL1RL1+-(2)_GFP_FOXI1\|(01)_IL1RL1+ / shred by cell type by condition	RBM25 CALD1 ATRX PRRC2C ZC3H13 NIPBL	1.88e-07	199	56	6	a2f7d0cabf35b80fe239fae34a77bf9344d5d743
ToppCell	TCGA-Bile_Duct-Primary_Tumor-Cholangiocarcinoma-Intrahepatic\|TCGA-Bile_Duct / Sample_Type by Project: Shred V9	NCOR2 ATN1 PRPF40B KCTD10 ENAH IQCE	1.93e-07	200	56	6	1fa8422fd820d21e285a7e7c4c6fbd8b7277d2af
ToppCell	Frontal_cortex-Neuronal-Inhibitory\|Frontal_cortex / BrainAtlas - Mouse McCarroll V32	CRACD NF2 PRRC2C SOCS5 UPF3B	2.31e-06	169	56	5	78eb70dd916724e476eabccf18fb7fcec4210308
ToppCell	Brain_organoid-organoid_Kanton_Nature\|Brain_organoid / Sample Type, Dataset, Time_group, and Cell type.	NCOR1 RBM25 PRRC2C LUC7L2 AFDN	3.59e-06	185	56	5	857c7ca8493e91ef1d0078ddafd6082020f9b169
ToppCell	droplet-Bladder-nan\|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	NCOR1 RBM25 PRRC2C SLTM NIPBL	3.78e-06	187	56	5	663991a8afe652e92363b64bcbd68c14d0307f0e
ToppCell	10x_3'_v2v3-Neoplastic-Stem-like-NPC-like-NPC-like_neural-C\|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	GSE1 CALD1 AFDN RIMS1 RERE	3.88e-06	188	56	5	e239bcdbd210a398a5850cb6fbf171d402f45a4f
ToppCell	renal_cortex_nuclei-Adult_normal_reference\|renal_cortex_nuclei / Celltypes from Cells and Nuclei per compartment and clinical group	LUC7L3 MYO10 PRRC2C AFDN AKAP13	3.98e-06	189	56	5	a48df46274d51e84ffb40264646de7346104efb9
ToppCell	PND10\|World / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	CALD1 ATRX AFDN EIF3A MAP4K4	4.09e-06	190	56	5	d67e2814047c8df2ae4b7bc8be9539f5df6ecef2
ToppCell	droplet-Thymus-nan-18m\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	NCOR1 ATRX LUC7L3 PRRC2C CEP97	4.41e-06	193	56	5	81871f4f2b63ca5f64a9ff12f6c909a34bf52216
ToppCell	droplet-Thymus-nan-18m-Lymphocytic\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	NCOR1 ATRX LUC7L3 PRRC2C CEP97	4.41e-06	193	56	5	12380713db6582749183a19de65d4af9d6469a3f
ToppCell	Smart-start-Cell-Wel_seq-Neoplastic-Stem-like-NPC-like-NPC-like_neural-E\|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	ZNF711 CRACD LUC7L3 AFDN UPF3B	4.52e-06	194	56	5	b111d10c99d7ff7eb261cd7786cd9d9a549049b1
ToppCell	droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	NCOR1 ATRX MYO10 PRRC2C RERE	4.64e-06	195	56	5	7796ea9247f4c63762f0de8490fed08b9717fa23
ToppCell	BAL-Mild-cDC_10\|Mild / Compartment, Disease Groups and Clusters	CRACD MINK1 CCDC81 MAP3K13 TNNT2	4.87e-06	197	56	5	c0550d41dd5619b369b590f3d6a61154dd7b2cab
ToppCell	(11)_FOXN4+-(2)_GFP_FOXI1\|(11)_FOXN4+ / shred by cell type by condition	RBM25 ATRX ZC3H13 SLTM NIPBL	5.00e-06	198	56	5	76d40b8c2f8399725b3a62ee2ae0896559cf91eb
ToppCell	PBMC_fresh-frozen\|World / Compartment, severity and other cell annotations on 10x 3' data (130k)	RBM25 ATRX LUC7L3 PRRC2C AKAP13	5.00e-06	198	56	5	dcc223a0396b8b673e4ed8c6733ec6cd74e9a03a
ToppCell	Neuron-Postmitotic-Excitatory_Neuron_-Newborn-35\|World / Primary Cells by Cluster	ATRX PRRC2C ZC3H13 ENAH MAP4K4	5.00e-06	198	56	5	de5214a85fe017eb23d4aa8af624464f062ec57e
ToppCell	mild-low-quality_cells\|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class	RBM25 ATRX LUC7L3 PRRC2C CDK11A	5.12e-06	199	56	5	f0b0097df0026496470a80d8cc9375ffd8389b00
ToppCell	(00)_Basal-(2)_GFP_FOXI1\|(00)_Basal / shred by cell type by condition	CALD1 ATRX PRRC2C ZC3H13 NIPBL	5.12e-06	199	56	5	19674e1eaeb51e4196d847cb62aa437c852951d3
ToppCell	(05)_Secretory-(2)_GFP_FOXI1\|(05)_Secretory / shred by cell type by condition	RBM25 ATRX PRRC2C ZC3H13 ITSN1	5.12e-06	199	56	5	d72d87e1e530ed894c0ad5e7b5b2b1d6b59fa098
ToppCell	(02)_MMP9/10+-(2)_GFP_FOXI1\|(02)_MMP9/10+ / shred by cell type by condition	CALD1 ATRX ZC3H13 ITSN2 NIPBL	5.12e-06	199	56	5	18a7f9ced4364f45b184bd529f32ef02c27779d3
ToppCell	(04)_Interm._basal>secr.-(2)_GFP_FOXI1\|(04)_Interm._basal>secr. / shred by cell type by condition	RBM25 ATRX PRRC2C ZC3H13 NIPBL	5.12e-06	199	56	5	53ca3861f9e00dab3f3fbefb0837857ee39ab084
ToppCell	(09)_Interm._secr.>cil.-(2)_GFP_FOXI1\|(09)_Interm._secr.>cil. / shred by cell type by condition	ATRX PRRC2C ZC3H13 ITSN1 NIPBL	5.12e-06	199	56	5	fc680f85ebd3bab4c72876a19a461b0afb5f51ce
ToppCell	(08)_Brush+PNEC-(2)_GFP_FOXI1\|(08)_Brush+PNEC / shred by cell type by condition	PRRC2C ZC3H13 ITSN1 NIPBL	2.75e-05	138	56	4	817e3f639604ea95adae01e8685ffaa2e0aff7a8
ToppCell	TCGA-Ovary-Primary_Tumor-Ovarian_Carcinoma-Serous_Cystadenocarcinoma-5\|TCGA-Ovary / Sample_Type by Project: Shred V9	PRPF40B GAS8 GIGYF2 AFDN	5.65e-05	166	56	4	32d2eaf8a5d03881bf74d680825af2d5110b082d
ToppCell	facs-Brain_Myeloid-Cerebellum-3m-Myeloid-nan\|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ATRX PRRC2C AKAP13 MAP4K4	6.63e-05	173	56	4	869da6a65d1b9b7529c666ec44e3c8ddec2ea408
ToppCell	facs-Brain_Myeloid-Cerebellum-3m-Myeloid\|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ATRX PRRC2C AKAP13 MAP4K4	6.63e-05	173	56	4	0672bd8a4a9d18af343d01f09253fb3388896c10
ToppCell	facs-Brain_Myeloid-Cerebellum-3m\|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ATRX PRRC2C AKAP13 MAP4K4	6.63e-05	173	56	4	870e091ec30be01a900e1cb8b9ef1880e3b7b50d
ToppCell	droplet-Limb_Muscle-MUSCLE-30m\|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ATRX MYO10 PRRC2C ITSN2	7.41e-05	178	56	4	01dafd19de04eff459253eaa9a35debf8f3deedf
ToppCell	droplet-Marrow-nan-3m-Hematologic\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	NCOR1 ATRX PRRC2C ITSN2	8.07e-05	182	56	4	1710eab3037a87609d21838be2d2d29c3bc36651
ToppCell	droplet-Marrow-nan-3m-Myeloid-nan\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ATRX PRRC2C ITSN2 NIPBL	8.07e-05	182	56	4	f8c73baaaca145e2efc48f10f636feb79c8fc779
ToppCell	droplet-Marrow-nan-3m-Hematologic-nan\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	NCOR1 ATRX PRRC2C ITSN2	8.07e-05	182	56	4	e78ba2c5cae480c16a596ce7c3bf2d480becacf4
ToppCell	droplet-Marrow-nan-3m-Myeloid\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ATRX PRRC2C ITSN2 NIPBL	8.60e-05	185	56	4	7adfa929930cfa795cbfbd9f1a0b439e08aa765d
ToppCell	droplet-Heart-nan-3m-Endothelial\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ATRX MYO10 PRRC2C AFDN	8.78e-05	186	56	4	0ae5fbe9f210cb25092394267e1d3d6ed05627b8
ToppCell	TCGA-Pancreas-Primary_Tumor-Pancreatic_Adenocarcinoma-Ductal_Adenocarcinoma-1\|TCGA-Pancreas / Sample_Type by Project: Shred V9	CRACD ATRX ZC3H13 GIGYF2	8.78e-05	186	56	4	03db813598b67b1e08f759758a1c2023396921fa
ToppCell	10x_3'_v2v3-Neoplastic-Differentiated-like-AC-like-AC-like-A\|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	CALD1 LUC7L3 MYO10 HDGFL2	8.96e-05	187	56	4	db771e952f71a12886c2dbc77c6cd07054ef809a
ToppCell	RV-15._Ventricular_Cardiomyocyte_III\|RV / Chamber and Cluster_Paper	CALD1 ENAH AKAP13 TNNT2	9.53e-05	190	56	4	93c3188dfeb0b2f9889f8ae9b9c1f2f34129c99b
ToppCell	PCW_13-14\|World / Celltypes from embryonic and fetal-stage human lung	NCOR1 GSE1 ENAH AFDN	9.53e-05	190	56	4	62a3ec1ae0829602b0569cc051210551644f1d46
ToppCell	Myeloid-Myeloid-B_(Activated_Macrophage)\|Myeloid / shred on cell class and cell subclass (v4)	RBM25 ZC3H13 EIF3A UPF3B	9.73e-05	191	56	4	7bf125249af1e8bb138ed4d999fdd74b03ab2447
ToppCell	human_hepatoblastoma-Tumor_cells\|World / Sample and Cell Type and Tumor Cluster (all cells)	LUC7L3 AFDN RERE NIPBL	9.92e-05	192	56	4	916fbec1c7ab7969bda711886ac88e877e30c280
ToppCell	nucseq-Mesenchymal-Myocytic-Myocytic_2\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	CRACD CALD1 ENAH TNNT2	1.01e-04	193	56	4	5de87fc94a6e58899ef4124cf4887ed3ff96163a
ToppCell	normal_Pleural_Fluid-Myeloid_cells-Activated_DCs\|normal_Pleural_Fluid / Location, Cell class and cell subclass	CRACD CCDC81 MAP3K13 TNNT2	1.03e-04	194	56	4	219056d4ad256cda73208b8c570bbf689219df83
ToppCell	normal_Pleural_Fluid-Myeloid_cells-Activated_DCs\|Myeloid_cells / Location, Cell class and cell subclass	AFDN CCDC81 MAP3K13 TNNT2	1.03e-04	194	56	4	30f683725cb13ae32ef6846618801ec78e12397d
ToppCell	droplet-Limb_Muscle-MUSCLE\|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ATRX MYO10 PRRC2C NIPBL	1.03e-04	194	56	4	e3d63874111d1e8da3977329426e4dcf68d6de87
ToppCell	PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic-mes_immature5_(6)\|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung	GSE1 MYO10 ENAH RERE	1.03e-04	194	56	4	b1bb0f846d2865efdd9bc8842b16b9d069785882
ToppCell	droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	NCOR1 ATRX PRRC2C RERE	1.05e-04	195	56	4	3e519cffa6144a62b06124642a14c9ff39b76554
ToppCell	Neuron-Postmitotic-Excitatory_Neuron_-IPC/newborn-38\|World / Primary Cells by Cluster	GSE1 CALD1 ATRX UBXN1	1.07e-04	196	56	4	38da0751941adca650fe9b383d9f343153978eb5
ToppCell	Neuron-Postmitotic-Excitatory_Neuron_-IPC/newborn\|World / Primary Cells by Cluster	GSE1 CALD1 ATRX UBXN1	1.07e-04	196	56	4	721650a08d260faf530dbd52d4e9275d27f3bac2
ToppCell	severe-low-quality_cells\|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class	RBM25 LUC7L3 PRRC2C CDK11A	1.10e-04	197	56	4	57ebd552f10d6278623b52a3d484d4b91ae1d028
ToppCell	Brain_organoid-organoid_Kanton_Nature-Organoid-2M-IPC_like\|Organoid-2M / Sample Type, Dataset, Time_group, and Cell type.	GSE1 CALD1 AFDN MAP4K4	1.12e-04	198	56	4	6d12ecaa9532c134d9c4562534dcb59a6420b4d3
ToppCell	Brain_organoid-organoid_Kanton_Nature-Organoid-2M-IPC_like-IPs_and_early_cortical_neurons\|Organoid-2M / Sample Type, Dataset, Time_group, and Cell type.	GSE1 CALD1 AFDN MAP4K4	1.12e-04	198	56	4	7943e4f67c3d6efb5c8b00aa0ff3cfe7be10c48d
ToppCell	kidney_cells-CKD+DKD_normotensive-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Proximal_Tubule_Epithelial_Cell\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	LUC7L3 PRRC2C AFDN AKAP13	1.14e-04	199	56	4	174f6013af6eafa577f84205a62927f2b367fda3
ToppCell	megakaryocytic-CD34+_Megakaryoblast\|megakaryocytic / Lineage and Cell class	RBM25 LUC7L3 PRRC2C EIF3A	1.14e-04	199	56	4	99a65887d3c8a2cde26693dd74404b101bba9d58
ToppCell	Brain_organoid-organoid_Tanaka_cellReport-10w-OPC_related-Oligodendrocyte/OPC\|10w / Sample Type, Dataset, Time_group, and Cell type.	GSE1 CALD1 MYO10 AFDN	1.16e-04	200	56	4	345f1eac498cc87fd7bf08e7312608b2d6fe1dd7
ToppCell	Brain_organoid-organoid_Tanaka_cellReport-6m-Neuronal-Intermediate\|6m / Sample Type, Dataset, Time_group, and Cell type.	RBM25 PRRC2C ZC3H13 NIPBL	1.16e-04	200	56	4	7c261e39ac30b318511373ab7302aa53b8b81b9c
ToppCell	COVID-19\|World / Disease, condition lineage and cell class	RBM25 PRRC2C AKAP13 NIPBL	1.16e-04	200	56	4	7dec470c379cd89f05a0f37c8628b21f136e52f0
ToppCell	Brain_organoid-organoid_Tanaka_cellReport-10w-OPC_related\|10w / Sample Type, Dataset, Time_group, and Cell type.	GSE1 CALD1 MYO10 AFDN	1.16e-04	200	56	4	8f5d98f962ddd8c4658c89ff8a2894de1228562a
ToppCell	Brain_organoid-organoid_Tanaka_cellReport-5w-Neuronal-Intermediate\|5w / Sample Type, Dataset, Time_group, and Cell type.	ATN1 GSE1 MAP4K4 PRRC2B	1.16e-04	200	56	4	c92e4fc0442404481fcac623d691dae6215b852d
Computational	Genes upregulated in subsets of cells of a given type within various tumors	ATRX LUC7L3 PRRC2C EIF3A	4.13e-05	49	43	4	GAVISH_3CA_MALIGNANT_METAPROGRAM_41_UNASSIGNED
Computational	Neighborhood of CSNK1D	CSNK1D PRRC2C UPF3A	2.73e-04	32	43	3	GCM_CSNK1D
Computational	Neighborhood of MLL	RBM25 NF2 LUC7L3 UPF3A PRRC2B	6.14e-04	174	43	5	GCM_MLL
Drug	Isoquinoline, 6,7-dimethoxy-1-methyl-1,2,3,4-tetrahydro, hydrochloride; Up 200; 16.4uM; MCF7; HT_HG-U133A	NCOR2 ATN1 CALD1 ZC3H13 MINK1 AFDN UBXN1	5.66e-07	199	56	7	4810_UP
Drug	Captopril [62571-86-2]; Down 200; 17.2uM; PC3; HT_HG-U133A	RBM25 CALD1 LUC7L3 MYO10 PRRC2C ACBD3	5.09e-06	179	56	6	4585_DN
Drug	Carbarsone [121-59-5]; Up 200; 15.4uM; MCF7; HT_HG-U133A	ATN1 CALD1 MINK1 AFDN UPF3A RERE	7.83e-06	193	56	6	3250_UP
Drug	Galanthamine hydrobromide [1953-04-4]; Down 200; 10.8uM; PC3; HT_HG-U133A	ATN1 MINK1 RERE UBXN1 PRRC2B IQCE	7.83e-06	193	56	6	4186_DN
Drug	Luteolin [491-70-3]; Down 200; 14uM; MCF7; HT_HG-U133A	WWC3 NF2 ITSN1 MINK1 NIPBL IQCE	8.31e-06	195	56	6	5004_DN
Drug	Fusaric acid [536-69-6]; Up 200; 22.4uM; MCF7; HT_HG-U133A	NCOR2 ATN1 MINK1 MAP3K13 RERE UBXN1	8.31e-06	195	56	6	4105_UP
Drug	Idoxuridine [54-42-2]; Down 200; 11.2uM; PC3; HT_HG-U133A	ATN1 NF2 MINK1 GAS8 RERE UBXN1	8.56e-06	196	56	6	4200_DN
Drug	Bucladesine sodium salt [16980-89-5]; Up 200; 7.8uM; HL60; HT_HG-U133A	ZNF711 NCOR2 CALD1 NF2 AFDN TNFAIP1	8.56e-06	196	56	6	2741_UP
Drug	Skimmianine [83-95-4]; Down 200; 15.4uM; MCF7; HT_HG-U133A	NF2 ITSN1 SOCS5 TNFAIP1 UPF3A NIPBL	9.07e-06	198	56	6	6242_DN
Drug	Palmatine chloride [3486-67-7]; Down 200; 10.4uM; PC3; HT_HG-U133A	NCOR2 ATN1 NF2 MYO10 AFDN AKAP13	9.60e-06	200	56	6	6612_DN
Drug	AC1NRBPQ	CALD1 NF2 MYO10 AFDN TNNT2	2.19e-05	137	56	5	CID005288569
Drug	halofenate	NCOR1 NCOR2	3.55e-05	4	56	2	CID000033584
Drug	thalicarpine	NCOR1 NCOR2 AKAP13	6.65e-05	32	56	3	CID000021470
Drug	Etifenin [63245-28-3]; Down 200; 12.4uM; PC3; HT_HG-U133A	RBM25 CALD1 PRRC2C AKAP13 ACBD3	7.64e-05	178	56	5	3998_DN
Drug	irinotecan HCl; Down 200; 100uM; MCF7; HT_HG-U133A	MYO10 ITSN2 GIGYF2 AKAP13 NIPBL	8.70e-05	183	56	5	7498_DN
Drug	ATN-2	ATN1 RERE	8.86e-05	6	56	2	CID003081684
Drug	Butamben [94-25-7]; Down 200; 20.6uM; PC3; HT_HG-U133A	NF2 AKAP13 TNFAIP1 UBXN1 PRRC2B	1.06e-04	191	56	5	5792_DN
Drug	Trifluridine [70-00-8]; Down 200; 13.6uM; MCF7; HT_HG-U133A	ATRX PRRC2C ITSN1 SOCS5 CEP97	1.09e-04	192	56	5	7176_DN
Drug	Indoprofen [31842-01-0]; Down 200; 14.2uM; PC3; HT_HG-U133A	ATN1 NF2 GAS8 TNFAIP1 MAP3K13	1.15e-04	194	56	5	4249_DN
Drug	Karakoline [39089-30-0]; Down 200; 10.6uM; MCF7; HT_HG-U133A	NCOR2 ATN1 ZC3H13 AKAP13 UPF3A	1.15e-04	194	56	5	4763_DN
Drug	Moxisylyte hydrochoride [964-52-3]; Down 200; 12.6uM; PC3; HT_HG-U133A	MINK1 AKAP13 UPF3A CEP97 IQCE	1.15e-04	194	56	5	1804_DN
Drug	(+)-Isoproterenol (+)-bitartrate salt [14638-70-1]; Down 200; 11uM; MCF7; HT_HG-U133A	ATN1 NF2 SOCS5 RERE UBXN1	1.15e-04	194	56	5	3384_DN
Drug	Flutamide [13311-84-7]; Down 200; 14.4uM; MCF7; HT_HG-U133A	RBM25 MYO10 PRRC2C AKAP13 ACBD3	1.15e-04	194	56	5	4361_DN
Drug	0317956-0000 [391210-11-0]; Up 200; 10uM; MCF7; HT_HG-U133A	NCOR2 ATN1 AFDN AKAP13 MAP3K13	1.15e-04	194	56	5	3855_UP
Drug	Ozagrel hydrochloride [78712-43-3]; Up 200; 15.2uM; HL60; HT_HG-U133A	RBM25 PRRC2C ITSN1 AFDN NIPBL	1.17e-04	195	56	5	2942_UP
Drug	Mycophenolic acid [24280-93-1]; Down 200; 12.4uM; PC3; HT_HG-U133A	ATN1 ATRX GAS8 AKAP13 UBXN1	1.17e-04	195	56	5	4019_DN
Drug	Apomorphine hydrochloride hemihydrate [41372-20-7]; Down 200; 6.4uM; MCF7; HT_HG-U133A	ATRX MYO10 AKAP13 TNFAIP1 IQCE	1.17e-04	195	56	5	1505_DN
Drug	6-Hydroxytropinone [5932-53-6]; Down 200; 25.8uM; PC3; HT_HG-U133A	ATN1 MINK1 TNFAIP1 MAP3K13 UBXN1	1.17e-04	195	56	5	4250_DN
Drug	Gallamine triethiodide [65-29-2]; Up 200; 4.4uM; MCF7; HT_HG-U133A	ATN1 NF2 RIMS1 CEP97 IQCE	1.17e-04	195	56	5	6215_UP
Drug	Selegiline hydrochloride [14611-52-0]; Down 200; 17.8uM; MCF7; HT_HG-U133A	NF2 MINK1 AKAP13 TNFAIP1 IQCE	1.17e-04	195	56	5	2826_DN
Drug	Flumethasone [2135-17-3]; Up 200; 9.8uM; PC3; HT_HG-U133A	NCOR2 ATN1 MINK1 MAP3K13 RERE	1.17e-04	195	56	5	4272_UP
Drug	Vitexin [3681-93-4]; Down 200; 9.2uM; MCF7; HT_HG-U133A	NCOR1 NF2 ITSN1 SOCS5 RERE	1.17e-04	195	56	5	2810_DN
Drug	Isopropamide iodide [71-81-8]; Down 200; 8.4uM; MCF7; HT_HG-U133A	MINK1 GAS8 TNFAIP1 RERE IQCE	1.17e-04	195	56	5	3461_DN
Drug	Ivermectin [70288-86-7]; Down 200; 4.6uM; PC3; HT_HG-U133A	RBM25 LUC7L2 EIF3A UPF3A PRRC2B	1.20e-04	196	56	5	2051_DN
Drug	Acenocoumarol [152-72-7]; Up 200; 11.4uM; MCF7; HT_HG-U133A	ATN1 CALD1 ATRX NF2 MINK1	1.20e-04	196	56	5	2240_UP
Drug	Levonordefrin [829-74-3]; Down 200; 21.8uM; HL60; HT_HG-U133A	NF2 MYO10 MINK1 RERE UBXN1	1.20e-04	196	56	5	2710_DN
Drug	quercetin dihydrate; Up 200; 1uM; MCF7; HT_HG-U133A_EA	ATRX NF2 MINK1 TNFAIP1 UBXN1	1.20e-04	196	56	5	917_UP
Drug	Oxybenzone [131-57-7]; Down 200; 17.6uM; PC3; HT_HG-U133A	FAM50B GSE1 NF2 UPF3A PRRC2B	1.20e-04	196	56	5	6309_DN
Drug	Seneciphylline [480-81-9]; Down 200; 12uM; PC3; HT_HG-U133A	ATN1 CALD1 MINK1 RERE UBXN1	1.20e-04	196	56	5	4238_DN
Drug	Aceclofenac [89796-99-6]; Up 200; 11.2uM; PC3; HT_HG-U133A	NCOR2 GAS8 AKAP13 UBXN1 IQCE	1.20e-04	196	56	5	7269_UP
Drug	Acetopromazine maleate salt [3598-37-6]; Down 200; 9uM; PC3; HT_HG-U133A	FAM50B ITSN1 MINK1 UPF3A RERE	1.20e-04	196	56	5	4494_DN
Drug	(-)-depudecin; Down 200; 1uM; MCF7; HT_HG-U133A_EA	NF2 ITSN1 MINK1 RERE NIPBL	1.20e-04	196	56	5	874_DN
Drug	Betulinic acid [472-15-1]; Up 200; 8.8uM; MCF7; HT_HG-U133A	ZNF711 ATN1 CALD1 AFDN UBXN1	1.23e-04	197	56	5	4181_UP
Drug	Flunixin meglumine [42461-84-7]; Down 200; 8.2uM; MCF7; HT_HG-U133A	ITSN1 SOCS5 UPF3A ACBD3 PRRC2B	1.23e-04	197	56	5	3411_DN
Drug	Azapropazone [13539-59-8]; Up 200; 13.4uM; HL60; HT_HG-U133A	ATN1 CALD1 NF2 GAS8 AFDN	1.23e-04	197	56	5	3143_UP
Drug	prazosin hydrochloride; Up 200; 10uM; MCF7; HT_HG-U133A_EA	CALD1 NF2 AFDN AKAP13 UBXN1	1.23e-04	197	56	5	826_UP
Drug	SC 19220; Down 200; 10uM; MCF7; HT_HG-U133A	RBM25 ATRX LUC7L3 NIPBL PRRC2B	1.23e-04	197	56	5	7060_DN
Drug	Dicloxacillin sodium salt [13412-64-1]; Up 200; 8.2uM; HL60; HT_HG-U133A	CALD1 NF2 ZC3H13 MINK1 AFDN	1.23e-04	197	56	5	2445_UP
Drug	Memantine Hydrochloride [41100-52-1]; Up 200; 18.6uM; MCF7; HT_HG-U133A	NCOR2 CALD1 RERE UBXN1 CEP97	1.23e-04	197	56	5	7354_UP
Drug	Hexamethonium dibromide dihydrate [55-97-0]; Down 200; 10uM; PC3; HT_HG-U133A	NCOR2 NF2 MINK1 AFDN IQCE	1.23e-04	197	56	5	6620_DN
Drug	Diprophylline [479-18-5]; Down 200; 15.8uM; MCF7; HT_HG-U133A	NF2 MYO10 SOCS5 EIF3A IQCE	1.23e-04	197	56	5	5482_DN
Drug	Iopamidol [60166-93-0]; Down 200; 5.2uM; MCF7; HT_HG-U133A	NF2 MYO10 MINK1 TNFAIP1 IQCE	1.23e-04	197	56	5	3473_DN
Drug	LY 294002; Up 200; 0.1uM; MCF7; HT_HG-U133A	ATRX NF2 LUC7L3 MINK1 AKAP13	1.23e-04	197	56	5	1641_UP
Drug	Chlortetracycline hydrochloride [64-72-2]; Down 200; 7.8uM; MCF7; HT_HG-U133A	ATRX NF2 PRRC2C TNFAIP1 UPF3A	1.23e-04	197	56	5	1541_DN
Drug	Gossypol [303-45-7]; Down 200; 7.8uM; MCF7; HT_HG-U133A	NCOR2 ATN1 RERE UBXN1 CEP97	1.26e-04	198	56	5	4762_DN
Drug	Mexiletine hydrochloride [5370-01-4]; Down 200; 18.6uM; HL60; HT_HG-U133A	NCOR1 WWC3 NF2 MINK1 AKAP13	1.26e-04	198	56	5	2364_DN
Drug	Lithocholic acid [434-13-9]; Down 200; 10.6uM; PC3; HT_HG-U133A	ZNF711 CALD1 NF2 MINK1 UBXN1	1.26e-04	198	56	5	4551_DN
Drug	Novobiocin sodium salt [1476-53-5]; Down 200; 6.4uM; PC3; HT_HG-U133A	ATN1 CALD1 TNFAIP1 RERE UBXN1	1.26e-04	198	56	5	4569_DN
Drug	Hydralazine hydrochloride [304-20-1]; Down 200; 20.4uM; PC3; HT_HG-U133A	NF2 MYO10 AKAP13 TNFAIP1 UBXN1	1.26e-04	198	56	5	4282_DN
Drug	Azapropazone [13539-59-8]; Up 200; 13.4uM; MCF7; HT_HG-U133A	CALD1 AFDN RIMS1 RERE IQCE	1.26e-04	198	56	5	6522_UP
Drug	Reserpine [50-55-5]; Down 200; 6.6uM; PC3; HT_HG-U133A	ATN1 MINK1 GAS8 RERE UBXN1	1.26e-04	198	56	5	4203_DN
Drug	ionomycin calcium salt; Down 200; 2uM; MCF7; HT_HG-U133A_EA	NF2 ITSN1 RERE NIPBL IQCE	1.26e-04	198	56	5	871_DN
Drug	Carbetapentane citrate [23142-01-0]; Down 200; 7.6uM; MCF7; HT_HG-U133A	ATRX NF2 LUC7L3 AKAP13 NIPBL	1.26e-04	198	56	5	2623_DN
Drug	Fluphenazine dihydrochloride [146-56-5]; Down 200; 7.8uM; PC3; HT_HG-U133A	FAM50B GSE1 MINK1 PRRC2B IQCE	1.26e-04	198	56	5	5880_DN
Drug	Acemetacin [53164-05-9]; Down 200; 9.6uM; MCF7; HT_HG-U133A	NCOR1 NF2 MINK1 TNFAIP1 UPF3A	1.26e-04	198	56	5	7442_DN
Drug	(S)-propranolol hydrochloride [4199-10-4]; Up 200; 13.6uM; PC3; HT_HG-U133A	NCOR2 MINK1 GAS8 AKAP13 UBXN1	1.29e-04	199	56	5	6343_UP
Drug	2-Chloropyrazine [14508-49-7]; Up 200; 35uM; MCF7; HT_HG-U133A	ATN1 CALD1 NF2 AKAP13 RERE	1.29e-04	199	56	5	3570_UP
Drug	Carbenoxolone disodium salt [7421-40-1]; Up 200; 6.6uM; MCF7; HT_HG-U133A	NCOR2 ATN1 NF2 ZC3H13 RERE	1.29e-04	199	56	5	3353_UP
Drug	Propranolol hydrochloride [318-98-9]; Down 200; 13.6uM; HL60; HT_HG-U133A	NCOR2 ATN1 NF2 MYO10 AFDN	1.29e-04	199	56	5	3059_DN
Drug	Diflunisal [22494-42-4]; Down 200; 16uM; PC3; HT_HG-U133A	ZNF711 ATN1 NF2 RERE UBXN1	1.29e-04	199	56	5	4210_DN
Drug	DNA-PK Inhibitor III; Down 200; 1uM; PC3; HT_HG-U133A	NCOR2 ATN1 CALD1 NF2 GAS8	1.29e-04	199	56	5	7548_DN
Drug	Flucloxacillin sodium [1847-24-1]; Down 200; 8.4uM; HL60; HT_HG-U133A	NF2 MYO10 ZC3H13 MINK1 UBXN1	1.29e-04	199	56	5	3128_DN
Drug	Bromopride [4093-35-0]; Down 200; 11.6uM; PC3; HT_HG-U133A	FAM50B NF2 MINK1 GAS8 RERE	1.29e-04	199	56	5	4278_DN
Drug	Procainamide hydrochloride [614-39-1]; Down 200; 14.8uM; MCF7; HT_HG-U133A	LUC7L3 TNFAIP1 MAP4K4 NIPBL PRRC2B	1.29e-04	199	56	5	2618_DN
Drug	Drofenine hydrochloride [548-66-3]; Down 200; 11.4uM; PC3; HT_HG-U133A	GSE1 NF2 AKAP13 UPF3A NIPBL	1.32e-04	200	56	5	7129_DN
Drug	Sulfinpyrazone [57-96-5]; Down 200; 9.8uM; HL60; HG-U133A	FAM50B MINK1 ITSN2 AKAP13 PRRC2B	1.32e-04	200	56	5	1574_DN
Drug	tetraiodothyroacetic acid	NCOR1 NCOR2	2.12e-04	9	56	2	ctd:C011126
Drug	geldanamycin	ZNF711 CALD1 ATRX NF2 PRRC2C NIPBL	2.94e-04	371	56	6	ctd:C001277
Drug	AC1L1ERB	NCOR1 NCOR2 MAP4K4	3.38e-04	55	56	3	CID000002914
Drug	Chloroprene	NCOR1 CALD1 ATRX LUC7L3 MYO10 ZC3H13 ITSN2 SLTM EIF3A MAP4K4 ACBD3	3.80e-04	1348	56	11	ctd:D002737
Drug	Androstenols	NCOR1 NCOR2	3.86e-04	12	56	2	ctd:D000737
Drug	dexamethasone oxetanone	NCOR1 NCOR2	3.86e-04	12	56	2	CID000063042
Drug	7,8-diaminopelargonic acid	NCOR1 ATN1	5.31e-04	14	56	2	CID000000652
Drug	iodine fluoride	AFDN EIF3A	6.11e-04	15	56	2	CID000522683
Drug	AC1L1E5T	NCOR1 NCOR2 TNFAIP1	8.07e-04	74	56	3	CID000002653
Drug	irinotecan HCl; Down 200; 100uM; PC3; HT_HG-U133A	ITSN1 GIGYF2 AKAP13 NIPBL	8.32e-04	171	56	4	7535_DN
Drug	irinotecan HCl; Down 200; 100uM; MCF7; HT_HG-U133A	MYO10 ITSN1 AKAP13 NIPBL	8.88e-04	174	56	4	7530_DN
Drug	Succimer	RBM25 ATRX LUC7L3 LUC7L2 ZC3H13 ITSN2 SLTM JDP2 GIGYF2 EIF3A	9.23e-04	1264	56	10	ctd:D004113
Drug	ICI 182,780; Down 200; 1uM; MCF7; HT_HG-U133A_EA	RBM25 PRRC2C AKAP13 ACBD3	9.46e-04	177	56	4	985_DN
Drug	Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; PC3; HT_HG-U133A	CSNK1D LUC7L2 SLTM PRRC2B	9.66e-04	178	56	4	7245_DN
Drug	Flumethasone [2135-17-3]; Up 200; 9.8uM; HL60; HT_HG-U133A	NCOR2 CALD1 NF2 ZC3H13	1.11e-03	185	56	4	2551_UP
Drug	Neostigmine bromide [114-80-7]; Down 200; 13.2uM; PC3; HT_HG-U133A	RBM25 MYO10 PRRC2C ACBD3	1.18e-03	188	56	4	6735_DN
Drug	nickel subsulfide	ATN1 LUC7L3 LUC7L2 TNNT2	1.18e-03	188	56	4	ctd:C017557
Drug	(+)-Isoproterenol (+)-bitartrate salt [14638-70-1]; Up 200; 11uM; HL60; HT_HG-U133A	CALD1 ZC3H13 GAS8 RERE	1.18e-03	188	56	4	3046_UP
Drug	Ketanserin tartrate hydrate [83846-83-7]; Down 200; 7uM; PC3; HT_HG-U133A	ATRX GAS8 AKAP13 TNFAIP1	1.21e-03	189	56	4	6649_DN
Drug	Resveratrol [501-36-0]; Down 200; 17.6uM; PC3; HT_HG-U133A	CALD1 ATRX MINK1 AKAP13	1.21e-03	189	56	4	5084_DN
Drug	Flupentixol dihydrochloride cis-(Z) [2413-38-9]; Down 200; 7.8uM; HL60; HT_HG-U133A	NCOR1 RBM25 PRRC2C AKAP13	1.21e-03	189	56	4	1288_DN
Drug	Mgamp-pnp	CALD1 MYO10	1.21e-03	21	56	2	CID005311323
Drug	Magnetite Nanoparticles	RBM25 ATRX LUC7L3 LUC7L2 ZC3H13 ITSN2 SLTM JDP2 GIGYF2 EIF3A	1.21e-03	1310	56	10	ctd:D058185
Drug	Thioguanosine [85-31-4]; Down 200; 12.6uM; MCF7; HT_HG-U133A	LUC7L3 ITSN1 ITSN2 NIPBL	1.23e-03	190	56	4	2619_DN
Disease	dentatorubral-pallidoluysian atrophy (implicated_via_orthology)	ATN1 RERE	3.29e-06	2	54	2	DOID:0060162 (implicated_via_orthology)
Disease	Mental Retardation, X-Linked	ZNF711 ATRX UPF3B	2.05e-05	29	54	3	C1136249
Disease	developmental disorder of mental health (implicated_via_orthology)	NCOR1 NCOR2 GIGYF2	1.01e-04	49	54	3	DOID:0060037 (implicated_via_orthology)
Disease	intellectual disability (implicated_via_orthology)	ATRX ITSN1 ITSN2	3.56e-04	75	54	3	DOID:1059 (implicated_via_orthology)
Disease	Glioblastoma Multiforme	NCOR1 ATRX LRRC59	1.12e-03	111	54	3	C1621958
Disease	serum gamma-glutamyl transferase measurement	NCOR2 RBM25 GSE1 CALD1 ATRX ENAH AKAP13	1.33e-03	914	54	7	EFO_0004532
Disease	Mental Retardation, X-Linked 1	ZNF711 UPF3B	1.57e-03	32	54	2	C2931498
Disease	platelet crit	GSE1 ATRX LEMD2 ZC3H18 EIF3A RERE HDGFL2	1.68e-03	952	54	7	EFO_0007985
Disease	Neoplasm of uncertain or unknown behavior of breast	NCOR1 MAP3K13	2.58e-03	41	54	2	C0496956
Disease	Breast adenocarcinoma	NCOR1 MAP3K13	2.58e-03	41	54	2	C0858252
Disease	schizophrenia, anorexia nervosa	GIGYF2 RERE	3.51e-03	48	54	2	MONDO_0005090, MONDO_0005351

Protein segments in the cluster

Peptide	Gene	Start	Entry
EEERRRQEEERTKRD	AFDN	1631	P55196
DEDEERERIERVRRI	KCTD10	286	Q9H3F6
DELRSRIRELEERDR	RNF40	701	O75150
EEERERERREKERER	RNF20	566	Q5VTR2
EDEETFELRDRVRRI	TNFAIP1	281	Q13829
EREREREADREREKE	GSE1	346	Q14687
READREREKERERER	GSE1	351	Q14687
EREKERERELERQRE	GSE1	376	Q14687
EREREREREKERERE	ATN1	816	P54259
EEKRRREREWEARER	AKAP13	2596	Q12802
REREWEARERELRER	AKAP13	2601	Q12802
ERQEIEKERRERERE	RBM25	301	P49756
EKSRDRERERERERE	RBM25	386	P49756
REEERRKDIERREAA	ITSN2	436	Q9NZM3
REGEEERREREEVLR	IQCE	436	Q6IPM2
DRERDRDREREKSIL	NCOR2	1801	Q9Y618
RRLEELERRRKEEEE	MAP4K4	436	O95819
LERRRKEEEERRRAE	MAP4K4	441	O95819
EARLRDEERLREEAR	LEMD2	41	Q8NC56
ERERQRRLEVEREAE	LRRC59	156	Q96AG4
SELDEEEERRKRRRE	JDP2	66	Q8WYK2
ADDAERERRDREERL	CSNK1D	301	P48730
EIERIERESAIERER	NIPBL	476	Q6KC79
KREEEERERERERRE	MYO10	831	Q9HD67
ERERERERREAELRA	MYO10	836	Q9HD67
EREKEREREREERER	LUC7L3	256	O95232
EERERKRRREEEERE	LUC7L3	266	O95232
EEEREKERARDRERR	LUC7L3	276	O95232
KEEEERRRREEEERE	ACBD3	191	Q9H3P7
RRRREEEERERLQKE	ACBD3	196	Q9H3P7
EEKRRREEEERLRRE	ACBD3	211	Q9H3P7
REEEERLRREEEERR	ACBD3	216	Q9H3P7
RLRREEEERRRIEEE	ACBD3	221	Q9H3P7
EEERRRIEEERLRLE	ACBD3	226	Q9H3P7
ELEARRRREQEEELR	HDGFL2	326	Q7Z4V5
REEAERTRDELERRL	NF2	346	P35240
EERERKERRESRRLE	RIMS1	306	Q86UR5
DEELIRRRREELRHA	MAP3K13	451	O43283
REEKREERRRREIER	UPF3B	211	Q9BZI7
REREREYERDQERIL	UPF3B	346	Q9BZI7
EYERDQERILRERER	UPF3B	351	Q9BZI7
EERRKRIAERERERE	ATRX	1501	P46100
QEEALRRLEERRREE	GIGYF2	816	Q6Y7W6
REERERAERAKREEE	EIF3A	826	Q14152
RELEIEERERRREEE	EIF3A	861	Q14152
EERERRREEERRLGD	EIF3A	866	Q14152
KDPERERDRERDVDR	EIF3A	1221	Q14152
YSEERRREIEDERLI	CCDC81	341	Q6ZN84
TDEIRRLRKERDEER	CEP97	601	Q8IW35
EDAERREREERERLE	CRACD	301	Q6ZU35
REREERERLEAEEER	CRACD	306	Q6ZU35
ERRRLEEDARLEERR	CRACD	331	Q6ZU35
EEDARLEERRRQEEE	CRACD	336	Q6ZU35
RQREEERRKEIERRE	ITSN1	421	Q15811
ERERRAEERRKEREA	CDK11A	181	Q9UQ88
LERERLERERLERER	ENAH	171	Q8N8S7
ERERLERLERERQER	ENAH	231	Q8N8S7
QERLKRREEREREER	LUC7L2	241	Q9Y383
RRIEEQKEERRRVEE	MINK1	396	Q8N4C8
STEDEEDRLRERRRL	SOCS5	256	O75159
ERAERVRRRLEEAER	TMEM191B	121	P0C7N4
ERAERVRRRLEEAER	TMEM191C	121	A6NGB0
IREEKREERRRRELE	UPF3A	231	Q9H1J1
SAEREREREREKERE	NCOR1	1711	O75376
REREREKERERERIA	NCOR1	1716	O75376
PEEIREREREKERER	PRRC2C	501	Q9Y520
IREREERERLQRERE	SLTM	651	Q9NWH9
ERERLQRERERLEIE	SLTM	656	Q9NWH9
EREREREREREAERA	RERE	1191	Q9P2R6
ERELREREIREREIR	RERE	1301	Q9P2R6
EREIREREIRERELR	RERE	1306	Q9P2R6
EAERARLEAEERERI	CALD1	266	Q05682
RLAEERARREEEENR	TNNT2	161	P45379
EAVERARKRREEEER	PRRC2B	501	Q5JSZ5
ARKRREEEERRAREE	PRRC2B	506	Q5JSZ5
LEREEEEERERARLR	PRPF40B	471	Q6NWY9
AEAREREREKEEARR	PRPF40B	611	Q6NWY9
QREREEREEREALER	UBXN1	106	Q04323
EREEREALERERQRR	UBXN1	111	Q04323
EEDDIRDERRVSRRY	ZNF711	301	Q9Y462
DVARLEEERERLEEE	WWC3	296	Q9ULE0
EEERERLEEELRRAR	WWC3	301	Q9ULE0
NDELERDERREERRV	ZC3H13	651	Q5T200
RDERREERRVDRVDD	ZC3H13	656	Q5T200
EERRVDRVDDRRDER	ZC3H13	661	Q5T200
ERDREREKERELERE	ZC3H13	696	Q5T200
REKERELERERARER	ZC3H13	701	Q5T200
ELERERARERERERE	ZC3H13	706	Q5T200
EREREKERDRERDRD	ZC3H13	716	Q5T200
ERERERERDREKERE	ZC3H13	736	Q5T200
RERDREKEREREREE	ZC3H13	741	Q5T200
EKEREREREERERER	ZC3H13	746	Q5T200
ERERERARERDKERE	ZC3H13	771	Q5T200
ERERDKRRDLDRERE	ZC3H13	1346	Q5T200
QRERERERERERDKE	ZC3H18	431	Q86VM9
SRIREELDREREERN	GAS8	36	O95995
RDREEEENRLREELR	FAM50B	156	Q9Y247